Any feedback?
Please rate this page
(enzyme.php)
(0/150)

BRENDA support

Disease on EC 2.4.1.1 - glycogen phosphorylase

Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
DISEASE
TITLE OF PUBLICATION
LINK TO PUBMED
6-phosphofructokinase deficiency
An oxidative defect in metabolic myopathies: diagnosis by noninvasive tissue oximetry.
Congenital and metabolic myopathies of childhood or adult onset.
Effect of fuels on exercise capacity in muscle phosphoglycerate mutase deficiency.
Free Mg2+ concentration in the calf muscle of glycogen phosphorylase and phosphofructokinase deficiency patients assessed in different metabolic conditions by 31P MRS.
Iodoacetate inhibition of glyceraldehyde-3-phosphate dehydrogenase as a model of human myophosphorylase deficiency (McArdle's disease) and phosphofructokinase deficiency (Tarui's disease).
Magnetic resonance imaging of muscle injury and atrophy in glycolytic myopathies.
Myopathies due to enzyme deficiencies.
Phosphoglycerate kinase deficiency in two brothers with McArdle-like clinical symptoms.
Phosphorus magnetic resonance spectroscopy (31P MRS) in neuromuscular disorders.
Sympathetic activation in exercise is not dependent on muscle acidosis. Direct evidence from studies in metabolic myopathies.
Acidosis
31-P NMR characterization of the metabolic anomalies associated with the lack of glycogen phosphorylase activity in human forearm muscle.
Effect of induced metabolic acidosis on human skeletal muscle metabolism during exercise.
Metabolic and energy correlates of intracellular pH in progressive fatigue of squid (L. brevis) mantle muscle.
Sympathetic activation in exercise is not dependent on muscle acidosis. Direct evidence from studies in metabolic myopathies.
Acidosis, Lactic
Convulsions as the etiology of lactic acidosis in acute diazinon toxicity in rats.
Acidosis, Respiratory
Skeletal muscle lactate release and glycolytic intermediates during hypercapnia.
Acute Coronary Syndrome
Cost-Effectiveness of Introducing Point-of-Care Test for Detection of Level of Glycogen Phosphorylase in Early Diagnostic Algorithm of Acute Coronary Syndrome.
Diagnostic accuracy of heart fatty acid binding protein (H-FABP) and glycogen phosphorylase isoenzyme BB (GPBB) in diagnosis of acute myocardial infarction in patients with acute coronary syndrome.
Direct comparison of the diagnostic value of point-of-care tests detecting heart-type fatty acid binding protein or glycogen phosphorylase isoenzyme BB in patients with acute coronary syndromes with persistent ST-segment elevation.
Glycogen phosphorylase BB in acute coronary syndromes.
Glycogen phosphorylase isoenzyme BB plasma concentration is elevated in pregnancy and preterm preeclampsia.
Performance of glycogen phosphorylase isoenzyme BB is weak in the detection of patients with non-ST-elevation acute coronary syndrome.
PP054. Elevated maternal plasma glycogen phosphorylase isoenzyme BB as time of disease biomarker of pre-eclampsia and small-for-gestational-age.
Prognostic Information of Glycogen Phosphorylase Isoenzyme BB in Patients With Suspected Acute Coronary Syndrome.
The diagnostic and prognostic value of first hour glycogen phosphorylase isoenzyme BB level in acute coronary syndrome.
Use of glycogen phosphorylase BB measurement with POCT in the diagnosis of acute coronary syndromes. A comparison with the ELISA method.
Acute Kidney Injury
Acute renal failure in McArdle's disease.
Pharmacological and nutritional treatment for McArdle disease (Glycogen Storage Disease type V).
[Rhabdomyolysis due to muscle enzyme deficiencies]
Adenocarcinoma
BGP expression in gastric biopsies may predict the development of new lesions after local treatment for early gastric cancer.
Metabolic sensitivity of pancreatic tumour cell apoptosis to glycogen phosphorylase inhibitor treatment.
Alkalosis
Effect of induced metabolic alkalosis on human skeletal muscle metabolism during exercise.
Alopecia
[Clinical and biochemical alterations in rats treated with high doses of vitamin A]
amidase deficiency
Severe rhabdomyolysis caused by Plasmodium vivax malaria in the Brazilian Amazon.
amp deaminase deficiency
Association of genetically proven deficiencies of myophosphorylase and AMP deaminase: a second case of 'double trouble'.
Double trouble: combined myophosphorylase and AMP deaminase deficiency in a child homozygous for nonsense mutations at both loci.
amylo-alpha-1,6-glucosidase deficiency
Myopathies due to enzyme deficiencies.
Pathological characteristics of glycogen storage disease III in skeletal muscle.
Anaphylaxis
Histochemical investigations on phosphorylase, branching enzyme and glycogen in guinea pig livers in experimental anaphylactic and histaminic shock.
Angina, Stable
Immunoenzymometric assay of human glycogen phosphorylase isoenzyme BB in diagnosis of ischemic myocardial injury.
Angina, Unstable
Early release of glycogen phosphorylase in patients with unstable angina and transient ST-T alterations.
Immunoenzymometric assay of human glycogen phosphorylase isoenzyme BB in diagnosis of ischemic myocardial injury.
[Effect of corinfar on the dynamic function and various indices of glycolysis and glycogenolysis in the thrombocytes of patients with unstable stenocardia]
Anthrax
Identification of Alzheimer's Disease Autoantibodies and Their Target Biomarkers by Phage Microarrays.
Arthrogryposis
Fatal arthrogryposis with respiratory insufficiency: a possible case of muscle phosphorylase b-kinase deficiency.
Astrocytoma
Beta adrenergic regulation of glycogen phosphorylase activity and adenosine cyclic 3', 5'-monophosphate accumulation in control and desensitized C-6 astrocytoma cells.
Human astrocytoma U251 RNA and genomic brain glycogen phosphorylase sequences.
Human brain glycogen phosphorylase. Cloning, sequence analysis, chromosomal mapping, tissue expression, and comparison with the human liver and muscle isozymes.
Ataxia Telangiectasia
Linkage studies of NIDDM with 23 chromosome 11 markers in a sample of whites of northern European descent.
Blister
Mechanism for the hepatotoxicity of the antiandrogen, nilutamide. Evidence suggesting that redox cycling of this nitroaromatic drug leads to oxidative stress in isolated hepatocytes.
The toxicity of acetaminophen and N-acetyl-p-benzoquinone imine in isolated hepatocytes is associated with thiol depletion and increased cytosolic Ca2+.
Toxicity of the antiandrogen flutamide in isolated rat hepatocytes.
Brain Diseases
Myophosphorylase deficiency affects muscle mitochondrial respiration as shown by 31P-MR spectroscopy in a case with associated multifocal encephalopathy.
Breast Neoplasms
Breast cancers utilize hypoxic glycogen stores via PYGB, the brain isoform of glycogen phosphorylase, to promote metastatic phenotypes.
Methylthioadenosine phosphorylase, a gene frequently codeleted with p16(cdkN2a/ARF), acts as a tumor suppressor in a breast cancer cell line.
Carcinogenesis
Carcinogenesis of intestinal-type gastric cancer and colorectal cancer is commonly accompanied by expression of brain (fetal)-type glycogen phosphorylase.
Expression of brain-type glycogen phosphorylase is a potentially novel early biomarker in the carcinogenesis of human colorectal carcinomas.
Gastric and intestinal phenotypes of gastric carcinoma with reference to expression of brain (fetal)-type glycogen phosphorylase.
Glycogen Phosphorylase B Is Regulated by miR101-3p and Promotes Hepatocellular Carcinoma Tumorigenesis.
Novel subtyping of intestinal metaplasia in the human stomach: brain-type glycogen phosphorylase expression in the proliferative zone and its relationship with carcinogenesis.
Carcinoma
Antigen reversion of glycogen phosphorylase isoenzyme in carcinoma and proliferative zone of intestinal metaplasia of the human stomach. An immunohistochemical study.
Carcinogenesis of intestinal-type gastric cancer and colorectal cancer is commonly accompanied by expression of brain (fetal)-type glycogen phosphorylase.
Elevated concentrations of brain-type glycogen phosphorylase in renal cell carcinoma.
Expression of brain-type glycogen phosphorylase is a potentially novel early biomarker in the carcinogenesis of human colorectal carcinomas.
Expression of glycogen phosphorylase activity in minute gastric carcinoma.
Flavopiridol inhibits glycogen phosphorylase by binding at the inhibitor site.
Frequent p53 mutation in brain (fetal)-type glycogen phosphorylase positive foci adjacent to human 'de novo' colorectal carcinomas.
Gastric and intestinal phenotypes of gastric carcinoma with reference to expression of brain (fetal)-type glycogen phosphorylase.
Genetic pathways of 'de novo' colorectal carcinomas with reference to fetal-type glycogen phosphorylase positive foci.
Histochemical studies of glycogen metabolizing enzymes in normal and abnormal human cervical epithelium.
Novel subtyping of intestinal metaplasia in the human stomach: brain-type glycogen phosphorylase expression in the proliferative zone and its relationship with carcinogenesis.
Nuclear localization of brain-type glycogen phosphorylase in some gastrointestinal carcinoma.
Carcinoma in Situ
Histochemical studies of glycogen metabolizing enzymes in normal and abnormal human cervical epithelium.
Carcinoma, Hepatocellular
Carcinofetal alterations in glycogen phosphorylase isozymes in rat hepatomas.
Disc electrophoretic study of the glycogen phosphorylase in ascites hepatoma. Its comparison with phosphorylases in fetal and adult rat livers and muscles.
Glycogen Phosphorylase B Is Regulated by miR101-3p and Promotes Hepatocellular Carcinoma Tumorigenesis.
Glycogen phosphorylase isoenzymes from hepatoma 3924A and from a non-tumorigenic liver cell line. Comparison with the liver and brain enzymes.
Isozyme patterns of glycogen phosphorylase in rat tissues and transplantable hepatomas.
Particulate-associated protein phosphatases of rat hepatomas as compared with the enzymes of rat liver.
Resolution of glycogen phosphorylase isoenzymes in precast PhastSystem polyacrylamide gels.
Studies on responsiveness of hepatoma cells to catecholamines. IV. Lack of adrenergic activation of phosphorylase in rat ascites hepatoma cells.
Studies on responsiveness of hepatoma cells to catecholamines. V. Loss of adrenergic response of glycogen phosphorylase in rat ascites hepatoma AH130 cells.
Carcinoma, Non-Small-Cell Lung
Flavopiridol inhibits glycogen phosphorylase by binding at the inhibitor site.
Glycogen phosphorylase B promotes cell proliferation and migration through PI3K/AKT pathway in non-small cell lung cancer.
PYGB Promoted Tumor Progression by Regulating Wnt/?-Catenin Pathway in Gastric Cancer.
Carcinoma, Renal Cell
Elevated concentrations of brain-type glycogen phosphorylase in renal cell carcinoma.
Cardiomegaly
Effect of acute ischemia on myocardial cyclic AMP, phosphorylase a, and lactate levels in various forms of cardiac hypertrophy. Correlation with cardiac norepinephrine stores.
Cardiomyopathies
Absence of myophosphorylase in ethanol induced cardiomyopathy.
Enzyme pattern in endomyocardial biopsies from patients with chronic heart diseases.
Cardiomyopathy, Hypertrophic
Plasma glycogen phosphorylase BB is associated with pulmonary artery wedge pressure and left ventricle mass index in patients with hypertrophic cardiomyopathy.
Cardiotoxicity
Caffeic Acid Protects against Iron-Induced Cardiotoxicity by Suppressing Angiotensin-Converting Enzyme Activity and Modulating Lipid Spectrum, Gluconeogenesis and Nucleotide Hydrolyzing Enzyme Activities.
Evaluation of Cardiac Markers in Children Undergoing Hematopoietic Stem Cell Transplantation.
Glycogen phosphorylase BB as a marker of cardiac toxicity during high-dose chemotherapy followed by hematopoietic cell transplantation.
Glycogen phosphorylase BB as a potential marker of cardiac toxicity in patients treated with anthracyclines for acute leukemia.
Glycogen phosphorylase BB could be a new biomarker for detection of cardiac toxicity during hematopoietic cell transplantation for hematological malignancies.
Glycogen phosphorylase BB could be a new circulating biomarker for detection of anthracycline cardiotoxicity.
Glycogen Phosphorylase Isoenzyme Bb, Myoglobin and BNP in ANT-Induced Cardiotoxicity.
Multimarker approach to evaluation of cardiac toxicity during preparative regimen and hematopoietic cell transplantation.
The use of cardiac biomarkers in detection of cardiotoxicity associated with conventional and high-dose chemotherapy for acute leukemia.
Use of multiple biomarkers for evaluation of anthracycline-induced cardiotoxicity in patients with acute myeloid leukemia.
Cardiovascular Diseases
Cardioprotective effects of ingliforib, a novel glycogen phosphorylase inhibitor.
Thymidine phosphorylase: A potential new target for treating cardiovascular disease.
carnitine o-palmitoyltransferase deficiency
Recurrent rhabdomyolysis in a collegiate athlete: a case report.
[Rhabdomyolysis due to muscle enzyme deficiencies]
Cholera
Post-receptor defect accounts for phosphorylase hypersensitivity in cultured diabetic cardiomyocytes.
Colonic Neoplasms
Glucose Metabolic Reprogramming and Cell Proliferation Arrest in Colorectal Micropapillary Carcinoma.
Integration of transcriptomics and metabolomics reveals anlotinib-induced cytotoxicity in colon cancer cells.
Colorectal Neoplasms
Carcinogenesis of intestinal-type gastric cancer and colorectal cancer is commonly accompanied by expression of brain (fetal)-type glycogen phosphorylase.
Expression of brain-type glycogen phosphorylase is a potentially novel early biomarker in the carcinogenesis of human colorectal carcinomas.
Frequent p53 mutation in brain (fetal)-type glycogen phosphorylase positive foci adjacent to human 'de novo' colorectal carcinomas.
Genetic pathways of 'de novo' colorectal carcinomas with reference to fetal-type glycogen phosphorylase positive foci.
PYGB Promoted Tumor Progression by Regulating Wnt/?-Catenin Pathway in Gastric Cancer.
Conjunctivitis
[Clinical and biochemical alterations in rats treated with high doses of vitamin A]
Contracture
A new variant of late-onset myophosphorylase deficiency.
Isoproterenol-induced relaxation, phosphorylase activation and cylic adenosine monophosphate levels in the polarized and depolarized rat uterus.
PYGM expression analysis in white blood cells: a complementary tool for diagnosing McArdle disease?
Coronary Occlusion
[Action of dopamine on glucose level and glycogen phosphorylase activity of blood plasma in experimental coronary occlusion]
Cysts
Amoebicidal activity of caffeine and maslinic acid by the induction of Programmed Cell Death in Acanthamoeba.
siRNA-loaded liposomes: Inhibition of encystment of Acanthamoeba and toxicity on the eye surface.
The therapeutic potential of a combination of two gene-specific siRNAs against clinical strains of Acanthamoeba.
Toxoplasma gondii Requires Glycogen Phosphorylase for Balancing Amylopectin Storage and for Efficient Production of Brain Cysts.
Cytochrome-c Oxidase Deficiency
An oxidative defect in metabolic myopathies: diagnosis by noninvasive tissue oximetry.
Diabetes Mellitus
Dual-Target Compounds against Type 2 Diabetes Mellitus: Proof of Concept for Sodium Dependent Glucose Transporter (SGLT) and Glycogen Phosphorylase (GP) Inhibitors.
Expression of the gene encoding glycogen phosphorylase is elevated in diabetic rat skeletal muscle and is regulated by insulin and cyclic AMP.
Glycogen phosphorylase inhibitors for treatment of type 2 diabetes mellitus.
Inhibition of brain-type glycogen phosphorylase ameliorates high glucose-induced cardiomyocyte apoptosis via Akt-HIF-1? activation.
Diabetes Mellitus, Experimental
Changes in the activity of enzymes, participating in glycogen metabolism of alloxan diabetic rats.
[Effect of trihydroxyoctadecadiene acids from Bryonia alba L. on the activity of glycogen metabolism enzymes in alloxan diabetes]
Diabetes Mellitus, Type 1
Intermittent and recurrent hepatomegaly due to glycogen storage in a patient with type 1 diabetes: genetic analysis of the liver glycogen phosphorylase gene (PYGL).
Diabetes Mellitus, Type 2
1-(3-Deoxy-3-fluoro-beta-d-glucopyranosyl) pyrimidine derivatives as inhibitors of glycogen phosphorylase b: Kinetic, crystallographic and modelling studies.
Acyl ureas as human liver glycogen phosphorylase inhibitors for the treatment of type 2 diabetes.
Anomeric Spironucleosides of ?-d-Glucopyranosyl Uracil as Potential Inhibitors of Glycogen Phosphorylase.
Anthranilimide based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes. Part 3: X-ray crystallographic characterization, core and urea optimization and in vivo efficacy.
Anthranilimide-based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes: 1. Identification of 1-amino-1-cycloalkyl carboxylic acid headgroups.
Anthranilimide-based glycogen phosphorylase inhibitors for the treatment of Type 2 diabetes: 2. Optimization of serine and threonine ether amino acid residues.
Binding evaluation of fragment-based scaffolds for probing allosteric enzymes.
Binding of N-acetyl-N '-beta-D-glucopyranosyl urea and N-benzoyl-N '-beta-D-glucopyranosyl urea to glycogen phosphorylase b: kinetic and crystallographic studies.
Computation as a Tool for Glycogen Phosphorylase Inhibitor Design.
Crystal structure of rabbit muscle glycogen phosphorylase a in complex with a potential hypoglycaemic drug at 2.0 A resolution.
Defects in liver and muscle glycogen metabolism in neonatal and adult New Zealand obese mice.
Dual-Target Compounds against Type 2 Diabetes Mellitus: Proof of Concept for Sodium Dependent Glucose Transporter (SGLT) and Glycogen Phosphorylase (GP) Inhibitors.
Evidence against glycogen cycling of gluconeogenic substrates in various liver preparations.
FR258900, a novel glycogen phosphorylase inhibitor isolated from Fungus No. 138354. I. Taxonomy, fermentation, isolation and biological activities.
Glucokinase and molecular aspects of liver glycogen metabolism.
Glucose-based spiro-oxathiazoles as in vivo anti-hyperglycemic agents through glycogen phosphorylase inhibition.
Glucose-derived spiro-isoxazolines are anti-hyperglycemic agents against type 2 diabetes through glycogen phosphorylase inhibition.
Glycogen phosphorylase as a molecular target for type 2 diabetes therapy.
Glycogen phosphorylase as a target for type 2 diabetes: synthetic, biochemical, structural and computational evaluation of novel N-acyl-N´-(?-D-glucopyranosyl) urea inhibitors.
Glycogen phosphorylase inhibition in type 2 diabetes therapy: a systematic evaluation of metabolic and functional effects in rat skeletal muscle.
Glycogen phosphorylase inhibitors for treatment of type 2 diabetes mellitus.
Identification, synthesis, and characterization of new glycogen phosphorylase inhibitors binding to the allosteric AMP site.
Increased epinephrine and skeletal muscle responses to hypoglycemia in non-insulin-dependent diabetes mellitus.
Inhibition of brain-type glycogen phosphorylase ameliorates high glucose-induced cardiomyocyte apoptosis via Akt-HIF-1? activation.
Inhibition of Glycogen Phosphorylase in the Context of Type 2 Diabetes, with Focus on Recent Inhibitors Bound at the Active Site.
Insulin resistance limits glucose utilization and exercise tolerance in myophosphorylase deficiency and NIDDM.
Insulin sensitivity is modified by a glycogen phosphorylase inhibitor: glucopyranosylidene-spiro-thiohydantoin in streptozotocin-induced diabetic rats.
Kinetic and crystallographic studies on 2-(beta-D-glucopyranosyl)-5-methyl-1, 3, 4-oxadiazole, -benzothiazole, and -benzimidazole, inhibitors of muscle glycogen phosphorylase b. Evidence for a new binding site.
Molecular recognition of the protein phosphatase 1 glycogen targeting subunit by glycogen phosphorylase.
New inhibitors of glycogen phosphorylase as potential antidiabetic agents.
Novel Liver-targeted conjugates of Glycogen Phosphorylase Inhibitor PSN-357 for the Treatment of Diabetes: Design, Synthesis, Pharmacokinetic and Pharmacological Evaluations.
Optimization and Validation of an In Vitro Standardized Glycogen Phosphorylase Activity Assay.
Pharmacokinetics and anti-hyperglycaemic efficacy of a novel inhibitor of glycogen phosphorylase, 1,4-dideoxy-1,4-imino-d- arabinitol, in glucagon-challenged rats and dogs and in diabetic ob/ob mice.
Physiological Control of Liver Glycogen Metabolism: Lessons from Novel Glycogen Phosphorylase Inhibitors.
Phytogenic Polyphenols as Glycogen Phosphorylase Inhibitors: The Potential of Triterpenes and Flavonoids for Glycaemic Control in Type 2 Diabetes.
Probing the ?-pocket of the active site of human liver glycogen phosphorylase with 3-(C-?-d-glucopyranosyl)-5-(4-substituted-phenyl)-1, 2, 4-triazole inhibitors.
Sensitivity of glycogen phosphorylase isoforms to indole site inhibitors is markedly dependent on the activation state of the enzyme.
Sourcing the affinity of flavonoids for the glycogen phosphorylase inhibitor site via crystallography, kinetics and QM/MM-PBSA binding studies: Comparison of chrysin and flavopiridol.
Structure based inhibitor design targeting glycogen phosphorylase B. Virtual screening, synthesis, biochemical and biological assessment of novel N-acyl-?-d-glucopyranosylamines.
Synthesis of 4-amidomethyl-1-glucosyl-1,2,3-triazoles and evaluation as glycogen phosphorylase inhibitors.
Synthesis of 5-halogenated 1,2,3-triazoles under stoichiometric Cu(I)-mediated azide-alkyne cycloaddition (CuAAC or 'Click Chemistry').
Synthesis of a C-glucosylated cyclopropylamide and evaluation as a glycogen phosphorylase inhibitor.
Synthesis of N-Glucopyranosidic Derivatives as Potential Inhibitors that Bind at the Catalytic Site of Glycogen Phosphorylase.
Synthesis, Kinetic and Conformational Studies of 2-Substituted-5-(?-d-glucopyranosyl)-pyrimidin-4-ones as Potential Inhibitors of Glycogen Phosphorylase.
The binding of ?-d-glucopyranosyl-thiosemicarbazone derivatives to glycogen phosphorylase: A new class of inhibitors.
The binding of beta- and gamma-cyclodextrins to glycogen phosphorylase b: kinetic and crystallographic studies.
The experimental type 2 diabetes therapy glycogen phosphorylase inhibition can impair aerobic muscle function during prolonged contraction.
Thermodynamic characterization of allosteric glycogen phosphorylase inhibitors.
Dyspnea
McArdle's disease presenting as unexplained dyspnea in a young woman.
Ectropion
Ectropion and epiphora in McArdle's syndrome.
Eczema
[Erythrocyte phosphorylase A activity in eczema]
Endometrial Neoplasms
Hormone dependency of carcinoma of the human endometrium. Effect of progesterone on glycogen metabolism in the carcinoma tissue.
[A histochemical study of the effect of progesterone on the carbohydrate metabolism enzymes of different morphologic forms of endometrial cancer]
Endometriosis
Endometriosis impairs glycogen synthesis in human endometrium.
Endotoxemia
Alterations in binding of inositol 1,4,5-trisphosphate to subcellular structures of rat liver during chronic endotoxemia.
Glycogen synthase and phosphorylase activities during glycogen repletion in endotoxemic rats.
Perturbation of transmembrane signaling mechanisms in acute and chronic endotoxemia.
Shift from alpha- to beta-type adrenergic receptor-mediated responses in chronically endotoxemic rats.
Foot-and-Mouth Disease
Active protein aggregates induced by terminally attached self-assembling peptide ELK16 in Escherichia coli.
Fructose Intolerance
Decrease and inhibition of liver glycogen phosphorylase after fructose. An experimental model for the study of hereditary fructose intolerance.
Genetic Diseases, Inborn
Localization of the muscle, liver, and brain glycogen phosphorylase genes on linkage maps of mouse chromosomes 19, 12, and 2, respectively.
Glioma
Calmodulin inhibitors activate glycogen phosphorylase B to A conversion in C6 glioma cells.
glucan 1,4-alpha-glucosidase deficiency
Congenital and metabolic myopathies of childhood or adult onset.
Glycogen storage diseases of muscle.
Myopathies due to enzyme deficiencies.
The glycogenoses: von Gierke's disease, acid maltase deficiency, and liver glycogen phosphorylase deficiency.
glycogen phosphorylase deficiency
31-P NMR characterization of the metabolic anomalies associated with the lack of glycogen phosphorylase activity in human forearm muscle.
A direct StyI polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) test for the myophosphorylase mutation in cattle.
A new stop codon mutation (Y52X) in the myophosphorylase gene in a Greek patient with McArdle's disease.
A new variant of late-onset myophosphorylase deficiency.
A novel missense mutation (W797R) in the myophosphorylase gene in Spanish patients with McArdle disease.
A proposed molecular diagnostic flowchart for myophosphorylase deficiency (McArdle disease) in blood samples from Spanish patients.
A thermodynamic function of glycogen in brain and muscle.
Absence of biochemical heterogeneity in McArdle's disease. A high resolution SDS-polyacrylamide gel electrophoresis study.
Absence of exercise-induced MRI enhancement of skeletal muscle in McArdle's disease.
Acute renal failure in McArdle's disease.
Adenovirus-mediated delivery into myocytes of muscle glycogen phosphorylase, the enzyme deficient in patients with glycogen-storage disease type V.
Aerobic conditioning: an effective therapy in McArdle's disease.
An A-to-C substitution involving the translation initiation codon in a patient with myophosphorylase deficiency (McArdle's disease).
An oxidative defect in metabolic myopathies: diagnosis by noninvasive tissue oximetry.
Analysis of spectrum and frequencies of mutations in McArdle disease. Identification of 13 novel mutations.
ATP degradation products after ischemic exercise: hereditary lack of phosphorylase or carnitine palmityltransferase.
Changes in force and intracellular metabolites during fatigue of human skeletal muscle.
Clinical and laboratory features of patients with myophosphorylase deficiency (McArdle disease).
Clinical spectrum of McArdle disease: three cases with unusual expression.
Clinical utility gene card for McArdle disease.
Cloning of bovine muscle glycogen phosphorylase cDNA and identification of a mutation in cattle with myophosphorylase deficiency, an animal model for McArdle's disease.
Congenital and metabolic myopathies of childhood or adult onset.
Congenital myopathy due to phosphorylase deficiency.
Creatine therapy in myophosphorylase deficiency (McArdle disease): a placebo-controlled crossover trial.
Depot-glucagon in the treatment of McArdle's disease.
Diagnosis of McArdle's disease by molecular genetic analysis of blood.
Differential glucose metabolism in mice and humans affected by McArdle disease.
Differential Muscle Involvement in Mice and Humans Affected by McArdle Disease.
Dominant inheritance of McArdle syndrome.
Early onset myophosphorylase deficiency (Mc Ardle's disease) with absence of myophosphorylase protein on SDS electrophoresis. The role of the ischemic forearm test.
Ectropion and epiphora in McArdle's syndrome.
Effect of fuels on exercise capacity in muscle phosphoglycerate mutase deficiency.
Electrophysiologic and histochemical observations in five patients with muscle phosphorylase deficiency (MPD).
Exercise induced fatigue: unfit or unwell?
Exercise tolerance and daily life in McArdle's disease.
Expression of muscle-type phosphorylase in innervated and aneural cultured muscle of patients with myophosphorylase deficiency.
Fasting as a provocative test in neuromuscular diseases.
Fat metabolism during exercise in patients with McArdle disease.
Fatal infantile form of muscle phosphorylase deficiency.
Fatal infantile muscle phosphorylase deficiency.
Fatigue in human metabolic myopathy.
Free Mg2+ concentration in the calf muscle of glycogen phosphorylase and phosphofructokinase deficiency patients assessed in different metabolic conditions by 31P MRS.
Genetic analysis of Japanese patients with myophosphorylase deficiency (McArdle's disease): single-codon deletion in exon 17 is the predominant mutation.
Genetic deficiencies of the glycogen phosphorylase system.
Genetic test for myophosphorylase deficiency in Charolais cattle.
Genotype modulators of clinical severity in McArdle disease.
Gentamicin treatment in McArdle disease: failure to correct myophosphorylase deficiency.
Glycogen storage disease: clinical, biochemical, and molecular heterogeneity.
Glycogen storage diseases of muscle.
Glycogenosis type V (McArdle's disease) mimicking atypical myositis.
Higher oxidative stress in skeletal muscle of McArdle disease patients.
Histochemical and biochemical studies in a patient with myophosphorylase deficiency.
HyperCKemia as the only sign of McArdle's disease in a child.
Hypoxanthine and Mcardle disease: a clue to metabolic stress in the working forearm.
Immunological studies on glycogen storage diseases type 3 and V. Demonstration of the presence of an immunoreactive protein in one case of muscle phosphorylase deficiency.
Impaired aerobic glycolysis in muscle phosphofructokinase deficiency results in biphasic post-exercise phosphocreatine recovery in 31P magnetic resonance spectroscopy.
Impaired oxidative metabolism increases adenine nucleotide breakdown in McArdle's disease.
Impaired oxygen extraction in metabolic myopathies: detection and quantification by near-infrared spectroscopy.
Impairment of sympathetic activation during static exercise in patients with muscle phosphorylase deficiency (McArdle's disease).
Increased PFK activity and GLUT4 protein content in McArdle's disease.
Insulin resistance limits glucose utilization and exercise tolerance in myophosphorylase deficiency and NIDDM.
Internal restriction sites: quality assurance aids in genotyping.
Iodoacetate inhibition of glyceraldehyde-3-phosphate dehydrogenase as a model of human myophosphorylase deficiency (McArdle's disease) and phosphofructokinase deficiency (Tarui's disease).
Laboratory diagnosis of the neuromuscular glycogen storage diseases.
Lactate and Energy Metabolism During Exercise in Patients With Blocked Glycogenolysis (McArdle Disease).
Lactate production in McArdle's disease.
Liver Glycogen Phosphorylase Deficiency Leads to Profibrogenic Phenotype in a Murine Model of Glycogen Storage Disease Type VI.
Liver glycogen phosphorylase deficiency.
Low muscle levels of pyridoxine in McArdle's syndrome.
Magnetic resonance imaging of muscle injury and atrophy in glycolytic myopathies.
McArdle disease: a novel mutation in Jewish families from the Caucasus region.
McArdle Disease: A Unique Study Model in Sports Medicine.
McArdle's disease presenting as recurrent cryptogenic renal failure due to occult seizures.
McArdle's disease presenting as treatment resistant polymyositis.
McArdle's disease presenting as unexplained dyspnea in a young woman.
McArdle's disease presenting with asymmetric, late-onset arm weakness.
McArdle's disease resembling an inflammatory myopathy.
McArdle's disease with late-onset symptoms: case report and review of the literature.
McArdle's disease with myoadenylate deaminase deficiency: observations in a combined enzyme deficiency.
McArdle's disease-muscle glycogen phosphorylase deficiency.
Mcardle's disease. A case report.
McArdle's disease: a study on the molecular basis of two different etiologies of myophosphorylase deficiency.
McArdle's disease: case report and review of the literature.
Metabolic basis of improved exercise tolerance: muscle phosphorylase deficiency after glucagon administration.
Metabolic control of cardiac output response to exercise in McArdle's disease.
Molecular analysis of myophosphorylase deficiency in Dutch patients with McArdle's disease.
Molecular characterization of McArdle's disease in two large Finnish families.
Molecular characterization of myophosphorylase deficiency (McArdle disease) in 34 patients from Southern France: identification of 10 new mutations. Absence of genotype-phenotype correlation.
Molecular characterization of myophosphorylase deficiency in a group of patients from northern Italy.
Molecular genetic heterogeneity of myophosphorylase deficiency (McArdle's disease).
Molecular genetic study of myophosphorylase deficiency (McArdle's disease) in two Yemenite-Jewish families.
Molecular heterogeneity of myophosphorylase deficiency (McArdle's disease): a genotype-phenotype correlation study.
Monocarboxylate transporters and mitochondrial creatine kinase protein content in McArdle disease.
Muscle accumulation of Tc-99m diphosphonate in myophosphorylase deficiency and other disorders of muscle glycogenolysis/glycolysis.
Muscle fatigue in McArdle's disease studied by 31P-NMR: effect of glucose infusion.
Muscle fatigue in McArdle's disease. Muscle fibre conduction velocity and surface EMG frequency spectrum during ischaemic exercise.
Muscle fatigue in myophosphorylase deficiency: power spectral analysis of the electromyogram.
Muscle Glycogen Phosphorylase and Its Functional Partners in Health and Disease.
Muscle glycogen phosphorylase deficiency.
Muscle glycogenosis and mitochondrial hepatopathy in an infant with mutations in both the myophosphorylase and deoxyguanosine kinase genes.
Muscle pain in myophosphorylase deficiency (McArdle's disease): the role of gender, genotype, and pain-related coping.
Muscle phosphorylase deficiency in childhood.
MUSCLE PHOSPHORYLASE DEFICIENCY.
Muscle Signaling in Exercise Intolerance: Insights from the McArdle Mouse Model.
Muscle-type phosphorylase activity present in muscle cells cultured from three patients with myophosphorylase deficiency.
Mutation analysis in myophosphorylase deficiency (McArdle's disease).
Myofibrillar activation failure in McArdle's disease.
Myoglobinuria and skeletal muscle phosphorylase deficiency: report of a case of McArdle's disease.
Myopathies due to enzyme deficiencies.
Myophosphorylase deficiency (glycogen storage disease Type V) in a herd of Charolais cattle in New Zealand: confirmation by PCR-RFLP testing.
Myophosphorylase deficiency (glycogenosis type V; McArdle disease).
Myophosphorylase deficiency (McArdle disease) in a patient with normal pregnancy and normal pregnancy outcome.
Myophosphorylase deficiency (McArdle's disease) in two interrelated families.
Myophosphorylase deficiency (McArdle's disease): report of a family.
Myophosphorylase deficiency affects muscle mitochondrial respiration as shown by 31P-MR spectroscopy in a case with associated multifocal encephalopathy.
Myophosphorylase deficiency and limb-girdle muscular dystrophy in the same pedigree.
Myophosphorylase deficiency associated with a defect in complex I of the mitochondrial respiratory chain.
Myophosphorylase deficiency associated with rhabdomyolysis and exercise intolerance in 6 related Charolais cattle.
Myophosphorylase deficiency impairs muscle oxidative metabolism.
Myophosphorylase deficiency: an unusually severe form with myoglobinuria.
Myophosphorylase deficiency: the course of an unusual congenital myopathy.
Myophosphorylase deficiency: two different molecular etiologies.
No spontaneous second wind in muscle phosphofructokinase deficiency.
Normal pregnancy and successful delivery in myophosphorylase deficiency (McArdle's disease).
Oxidative stress and Nrf2 signaling in McArdle disease.
Oxygen consumption is increased relative to work rate in patients with McArdle's disease.
Pathophysiology of exercise performance in muscle disease.
Peripheral nerve and vasculature involvement in myophosphorylase deficiency (McArdle's disease).
Phenotype modulators in myophosphorylase deficiency.
Phosphoglycerate kinase deficiency in two brothers with McArdle-like clinical symptoms.
Phosphorus magnetic resonance spectroscopy (31P MRS) in neuromuscular disorders.
Phosphorylase a deficiency in pseudohypoparathyroidism.
Phosphorylase isoenzymes in normal and myophosphorylase-deficient human heart.
Phosphorylation of McArdle phosphorylase induces activity.
Physiologic assessment of phosphoglycerate mutase deficiency: incremental exercise test.
Protein and amino acid metabolism in human muscle.
Recurrent myoglobinuria due to muscle carnitine palmityl transferase deficiency.
Recurrent rhabdomyolysis in a collegiate athlete: a case report.
Reflex sympathetic activation during static exercise is severely impaired in patients with myophosphorylase deficiency.
Single-fiber electromyography in neuromuscular disorders: correlation of muscle histochemistry, single-fiber electromyography, and clinical findings.
Spontaneous "second wind" and glucose-induced second "second wind" in McArdle disease: oxidative mechanisms.
Study of myopathy in chronic alcoholics with neurological complication.
Substrate kinetics in patients with disorders of skeletal muscle metabolism.
Successful pregnancy in a woman with glycogen storage disease type 6.
Sudden infant death syndrome (SIDS) in a family with myophosphorylase deficiency.
The effect of three test meals on exercise tolerance of an individual with McArdle's disease.
The glycogenoses: von Gierke's disease, acid maltase deficiency, and liver glycogen phosphorylase deficiency.
The metabolic causes of slow relaxation in fatigued human skeletal muscle.
The molecular genetic basis of myophosphorylase deficiency (McArdle's disease).
The pathophysiology of McArdle's disease: clues to regulation in exercise and fatigue.
The polymorphic locus for glycogen storage disease VI (liver glycogen phosphorylase) maps to chromosome 14.
The production, buffering and efflux of protons in human skeletal muscle during exercise and recovery.
Three new mutations in patients with myophosphorylase deficiency (McArdle disease).
Translational Medicine: Exercise Physiology Applied to Metabolic Myopathies.
Tricarboxylic acid cycle intermediates during incremental exercise in healthy subjects and in patients with McArdle's disease.
Two new mutations in the myophosphorylase gene in Italian patients with McArdle's disease.
Two novel missense mutations (E654K, L396P) in Caucasian patients with myophosphorylase deficiency (McArdle's disease).
Two novel mutations in the muscle glycogen phosphorylase gene in McArdle's disease.
Unforeseen Cardiac Involvement in McArdle's Disease.
Various classes of mutations in patients with phosphofructokinase deficiency (Tarui's disease).
[Acute renal failure due to rhabdomyolysis in McArdle's disease following binge drinking with seizures]
[Glycogenosis type V of adults: muscle phosphorylase deficiency]
[Late diagnosis of a McArdle disease's case (type V glycogenosis).]
[McArdle disease revealed by exercise intolerance associated with severe rhabdomyolysis]
[McArdle disease: report of four brothers with myophosphorylase deficiency]
[McArdle's disease--description based on three own observations (author's transl)]
[McArdle's disease. Apropos of a case]
[Muscle phosphorylase deficiency in childhood. A case report]
[Myalgia during warming-up in a 12-year-old boy].
[Myophosphorylase deficiency]
[On progressive myopathy with muscle phosphorylase deficiency and giant mitochondria]
[Rhabdomyolysis due to muscle enzyme deficiencies]
[Study of metabolic myopathies using 1H NMR spectroscopy--analysis of muscle metabolites and muscle autolytic change]
Glycogen Storage Disease
A novel mutation (G233D) in the glycogen phosphorylase gene in a patient with hepatic glycogen storage disease and residual enzyme activity.
Acute renal failure due to rhabdomyolysis in a child with McArdle disease.
Anesthesia considerations in a patient with mcArdle disease: a case report.
Clinical and molecular characterization of McArdle's disease in Brazilian patients.
Clinical Presentation and Management of Severe Acute Renal Failure in McArdle Disease.
Differential glucose metabolism in mice and humans affected by McArdle disease.
Differential Muscle Involvement in Mice and Humans Affected by McArdle Disease.
Fatal infantile muscle phosphorylase deficiency.
Genetic deficiencies of the glycogen phosphorylase system.
Glycogen storage disease type VI: clinical course and molecular background.
Glycogen storage diseases of muscle.
Glycogenosis due to liver and muscle phosphorylase kinase deficiency.
High frequency of missense mutations in glycogen storage disease type VI.
Identification of a mutation in liver glycogen phosphorylase in glycogen storage disease type VI.
Immunological studies on glycogen storage diseases type 3 and V. Demonstration of the presence of an immunoreactive protein in one case of muscle phosphorylase deficiency.
Knock-in mice for the R50X mutation in the PYGM gene present with McArdle disease.
Lack of muscle mTOR kinase activity causes early onset myopathy and compromises whole-body homeostasis.
Liver Glycogen Phosphorylase Deficiency Leads to Profibrogenic Phenotype in a Murine Model of Glycogen Storage Disease Type VI.
McArdle disease: molecular genetic update.
McArdle disease: the mutation spectrum of PYGM in a large Italian cohort.
McArdle disease: what do neurologists need to know?
McArdle's disease presenting with asymmetric, late-onset arm weakness.
McArdle's disease: case report and review of the literature.
Muscle glycogenosis and mitochondrial hepatopathy in an infant with mutations in both the myophosphorylase and deoxyguanosine kinase genes.
Muscle phosphorylase kinase deficiency: a neutral metabolic variant or a disease?
Mutation analysis in myophosphorylase deficiency (McArdle's disease).
Mutations in the liver glycogen phosphorylase gene (PYGL) underlying glycogenosis type VI.
Myopathies due to enzyme deficiencies.
Novel variant in the PYGM gene causing late-onset limb-girdle myopathy, ptosis, and camptocormia.
Phosphoglycerate kinase deficiency in two brothers with McArdle-like clinical symptoms.
Prolonged inhibition of glycogen phosphorylase in livers of Zucker Diabetic Fatty rats models human glycogen storage diseases.
Regional localization of loci on chromosome 14 using somatic cell hybrids.
Rhabdomyolysis in a patient with McArdle's disease.
Six novel mutations in the myophosphorylase gene in patients with McArdle disease and a family with pseudo-dominant inheritance pattern.
Studies on a patient with in vivo evidence of type I glycogenosis and normal enzyme activities in vitro.
Successful pregnancy in a woman with glycogen storage disease type 6.
The behavior of hepatic phosphorylase b kinase, phosphorylase a and b after administration of glucagon to patients with glycogen storage disease type VIa.
The glycogenoses: von Gierke's disease, acid maltase deficiency, and liver glycogen phosphorylase deficiency.
The Phenotypic and Genetic Spectrum of Glycogen Storage Disease Type VI.
The polymorphic locus for glycogen storage disease VI (liver glycogen phosphorylase) maps to chromosome 14.
[A case of acute renal failure secondary to late-onset McArdle's disease].
[A case of glycogen storage myopathy with acute heart failure]
[Anesthesia for cesarean section in a patient with McArdle disease and hereditary dilated cardiomyopathy]
[Glycogen storage disease associated with glycogen deposition in skeletal and heart muscles with low muscle phosphorylase activity]
[Glycogenosis type V of adults: muscle phosphorylase deficiency]
[Massive rhabdomyolysis revealing a McArdle disease.]
[One rare case report of acute renal insufficiency in rhabdomyolysis]
[Successful treatment with infliximab of a patient with refractory sarcoidosis]
Glycogen Storage Disease Type I
The glycogenoses: von Gierke's disease, acid maltase deficiency, and liver glycogen phosphorylase deficiency.
Glycogen Storage Disease Type II
Congenital and metabolic myopathies of childhood or adult onset.
Glycogen storage diseases of muscle.
Myopathies due to enzyme deficiencies.
The glycogenoses: von Gierke's disease, acid maltase deficiency, and liver glycogen phosphorylase deficiency.
Glycogen Storage Disease Type III
Pathological characteristics of glycogen storage disease III in skeletal muscle.
Glycogen Storage Disease Type V
31-P NMR characterization of the metabolic anomalies associated with the lack of glycogen phosphorylase activity in human forearm muscle.
A case of McArdle disease: efficacy of vitamin B6 on fatigability and impaired glycogenolysis.
A direct StyI polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) test for the myophosphorylase mutation in cattle.
A High Creatine Kinase Concentration Might Be a Sign of McArdle Disease in Patient With Type 1 Diabetes.
A homozygous missense mutation (A659D) in the myophosphorylase gene in a Spanish patient with McArdle's disease.
A missense mutation T487N in the myophosphorylase gene in a Spanish patient with McArdle's disease.
A missense mutation W797R in the myophosphorylase gene in a Spanish patient with McArdle's disease.
A multi-parametric protocol to study exercise intolerance in McArdle's disease.
A New Condition in McArdle Disease: Poor Bone Health-Benefits of an Active Lifestyle.
A new mutation in the myophosphorylase gene (Asn684Tyr) in a Spanish patient with McArdle's disease.
A new mutation in the regulatory domain of the myophosphorylase gene affecting protein dimer contact.
A new rare mutation (691delCC/insAAA) in exon 17 of the PYGM gene causing McArdle disease.
A new stop codon mutation (Y52X) in the myophosphorylase gene in a Greek patient with McArdle's disease.
A new variant of late-onset myophosphorylase deficiency.
A nonsense mutation in the myophosphorylase gene in a Japanese family with McArdle's disease.
A novel missense mutation (W797R) in the myophosphorylase gene in Spanish patients with McArdle disease.
A novel mutation in the PYGM gene in a family with pseudo-dominant transmission of McArdle disease.
A novel nonsense mutation (R269X) in the myophosphorylase gene in a patient with McArdle disease.
A proposed molecular diagnostic flowchart for myophosphorylase deficiency (McArdle disease) in blood samples from Spanish patients.
A splice-site mutation causing ovine McArdle's disease.
A thermodynamic function of glycogen in brain and muscle.
A Transcriptomic Approach to Search for Novel Phenotypic Regulators in McArdle Disease.
Absence of biochemical heterogeneity in McArdle's disease. A high resolution SDS-polyacrylamide gel electrophoresis study.
Absence of exercise-induced MRI enhancement of skeletal muscle in McArdle's disease.
Absence of functional messenger RNA for glycogen phosphorylase in the muscle of two patients with McArdle's disease.
Absence of p.R50X Pygm read-through in McArdle disease cellular models.
Acid maltase deficiency and related myopathies.
Acute renal failure in McArdle's disease.
Adenovirus and adeno-associated virus-mediated delivery of human myophosphorylase cDNA and LacZ cDNA to muscle in the ovine model of McArdle's disease: Expression and re-expression of glycogen phosphorylase.
Adenovirus-mediated delivery into myocytes of muscle glycogen phosphorylase, the enzyme deficient in patients with glycogen-storage disease type V.
Aerobic conditioning: an effective therapy in McArdle's disease.
An A-to-C substitution involving the translation initiation codon in a patient with myophosphorylase deficiency (McArdle's disease).
An elderly diabetic patient with McArdle disease and recurrent rhabdomyolysis: a potential association with late hypoinsulinemia?
An oxidative defect in metabolic myopathies: diagnosis by noninvasive tissue oximetry.
Analysis of spectrum and frequencies of mutations in McArdle disease. Identification of 13 novel mutations.
Anesthesia considerations in a patient with mcArdle disease: a case report.
Asymptomatic McArdle's disease associated with hyper-creatine kinase-emia and absence of myophosphorylase.
ATP degradation products after ischemic exercise: hereditary lack of phosphorylase or carnitine palmityltransferase.
Cell models for McArdle disease and aminoglycoside-induced read-through of a premature termination codon.
Changes in force and intracellular metabolites during fatigue of human skeletal muscle.
Characterization of glycogen phosphorylase isoenzymes present in cultured skeletal muscle from patients with McArdle's disease.
Clinical and laboratory features of patients with myophosphorylase deficiency (McArdle disease).
Clinical and molecular characterization of McArdle's disease in Brazilian patients.
Clinical Presentation and Management of Severe Acute Renal Failure in McArdle Disease.
Clinical spectrum of McArdle disease: three cases with unusual expression.
Clinical utility gene card for McArdle disease.
Cloning of bovine muscle glycogen phosphorylase cDNA and identification of a mutation in cattle with myophosphorylase deficiency, an animal model for McArdle's disease.
Cognitive impairment and McArdle disease: Is there a link?
Congenital and metabolic myopathies of childhood or adult onset.
Congenital myopathy due to phosphorylase deficiency.
Creatine therapy in myophosphorylase deficiency (McArdle disease): a placebo-controlled crossover trial.
Depot-glucagon in the treatment of McArdle's disease.
Diagnosis of McArdle's disease by molecular genetic analysis of blood.
Differential glucose metabolism in mice and humans affected by McArdle disease.
Differential Muscle Involvement in Mice and Humans Affected by McArdle Disease.
Do carriers of PYGM mutations have symptoms of McArdle disease?
Dominant inheritance of McArdle syndrome.
Early onset myophosphorylase deficiency (Mc Ardle's disease) with absence of myophosphorylase protein on SDS electrophoresis. The role of the ischemic forearm test.
Ectropion and epiphora in McArdle's syndrome.
Effect of fuels on exercise capacity in muscle phosphoglycerate mutase deficiency.
Electrophysiologic and histochemical observations in five patients with muscle phosphorylase deficiency (MPD).
Exercise and Preexercise Nutrition as Treatment for McArdle Disease.
Exercise induced fatigue: unfit or unwell?
Exercise tolerance and daily life in McArdle's disease.
Exercising with blocked muscle glycogenolysis: Adaptation in the McArdle mouse.
Expression of glycogen phosphorylase isoforms in cultured muscle from patients with McArdle's disease carrying the p.R771PfsX33 PYGM mutation.
Expression of muscle-type phosphorylase in innervated and aneural cultured muscle of patients with myophosphorylase deficiency.
Expression of the muscle glycogen phosphorylase gene in patients with McArdle disease: the role of nonsense-mediated mRNA decay.
Fasting as a provocative test in neuromuscular diseases.
Fat metabolism during exercise in patients with McArdle disease.
Fatal infantile form of muscle phosphorylase deficiency.
Fatal infantile muscle phosphorylase deficiency.
Fatigue in human metabolic myopathy.
Free Mg2+ concentration in the calf muscle of glycogen phosphorylase and phosphofructokinase deficiency patients assessed in different metabolic conditions by 31P MRS.
Genes and exercise intolerance: insights from McArdle disease.
Genetic analysis of Japanese patients with myophosphorylase deficiency (McArdle's disease): single-codon deletion in exon 17 is the predominant mutation.
Genetic deficiencies of the glycogen phosphorylase system.
Genetic test for myophosphorylase deficiency in Charolais cattle.
Genotype modulators of clinical severity in McArdle disease.
Gentamicin treatment in McArdle disease: failure to correct myophosphorylase deficiency.
Glycogen storage disease: clinical, biochemical, and molecular heterogeneity.
Glycogen storage diseases of muscle.
Glycogenosis type V (McArdle's disease) mimicking atypical myositis.
High frequency of missense mutations in glycogen storage disease type VI.
High-resolution melting facilitates mutation screening of PYGM in patients with McArdle disease.
Higher oxidative stress in skeletal muscle of McArdle disease patients.
Histochemical and biochemical studies in a patient with myophosphorylase deficiency.
Homozygosity by descent for a rare mutation in the myophosphorylase gene is associated with variable phenotypes in a Druze family with McArdle disease.
HyperCKemia as the only sign of McArdle's disease in a child.
Hypoxanthine and Mcardle disease: a clue to metabolic stress in the working forearm.
Immunological studies on glycogen storage diseases type 3 and V. Demonstration of the presence of an immunoreactive protein in one case of muscle phosphorylase deficiency.
Impaired aerobic glycolysis in muscle phosphofructokinase deficiency results in biphasic post-exercise phosphocreatine recovery in 31P magnetic resonance spectroscopy.
Impaired oxidative metabolism increases adenine nucleotide breakdown in McArdle's disease.
Impaired oxygen extraction in metabolic myopathies: detection and quantification by near-infrared spectroscopy.
Impairment of sympathetic activation during static exercise in patients with muscle phosphorylase deficiency (McArdle's disease).
Increased PFK activity and GLUT4 protein content in McArdle's disease.
Insulin resistance limits glucose utilization and exercise tolerance in myophosphorylase deficiency and NIDDM.
Internal restriction sites: quality assurance aids in genotyping.
Interrelationships between metabolism of glycogen phosphorylase and pyridoxal phosphate--implications in McArdle's disease.
Investigating sodium valproate as a treatment for McArdle disease in sheep.
Iodoacetate inhibition of glyceraldehyde-3-phosphate dehydrogenase as a model of human myophosphorylase deficiency (McArdle's disease) and phosphofructokinase deficiency (Tarui's disease).
Knock-in mice for the R50X mutation in the PYGM gene present with McArdle disease.
Laboratory diagnosis of the neuromuscular glycogen storage diseases.
Lack of muscle mTOR kinase activity causes early onset myopathy and compromises whole-body homeostasis.
Lactate and Energy Metabolism During Exercise in Patients With Blocked Glycogenolysis (McArdle Disease).
Lactate production in McArdle's disease.
Late-onset Mcardle's disease with unusual electromyographic findings.
Localization of the muscle, liver, and brain glycogen phosphorylase genes on linkage maps of mouse chromosomes 19, 12, and 2, respectively.
Low muscle levels of pyridoxine in McArdle's syndrome.
Low survival rate and muscle fiber-dependent aging effects in the McArdle disease mouse model.
Magnetic resonance imaging of muscle injury and atrophy in glycolytic myopathies.
Manifesting heterozygotes in McArdle disease: a myth or a reality-role of statins.
McArdle Disease and Exercise Physiology.
McArdle disease: 2 case reports.
McArdle disease: a case report and review.
McArdle disease: a novel mutation in Jewish families from the Caucasus region.
McArdle Disease: A Unique Study Model in Sports Medicine.
McArdle disease: another systemic low-inflammation disorder?
McArdle Disease: Clinical, Biochemical, Histological and Molecular Genetic Analysis of 60 Patients.
McArdle disease: molecular genetic update.
McArdle Disease: New Insights into Its Underlying Molecular Mechanisms.
McArdle disease: the mutation spectrum of PYGM in a large Italian cohort.
McArdle disease: the mystery of reappearing phosphorylase activity in muscle culture--a fetal isoenzyme.
McArdle Disease: Update of Reported Mutations and Polymorphisms in the PYGM Gene.
McArdle disease: what do neurologists need to know?
McArdle's disease associated with homozygosity for the missense mutation Gly204Ser of the myophosphorylase gene in a Spanish patient.
McArdle's disease diagnosed following statin-induced myositis.
McArdle's disease heterozygotes. Metabolic adaptation assessed using 31P-nuclear magnetic resonance.
McArdle's disease in two generations: autosomal recessive transmission with manifesting heterozygote.
McArdle's disease presenting as recurrent cryptogenic renal failure due to occult seizures.
McArdle's disease presenting as treatment resistant polymyositis.
McArdle's disease presenting as unexplained dyspnea in a young woman.
McArdle's disease presenting with asymmetric, late-onset arm weakness.
McArdle's disease resembling an inflammatory myopathy.
McArdle's disease with late-onset symptoms: case report and review of the literature.
McArdle's disease with myoadenylate deaminase deficiency: observations in a combined enzyme deficiency.
McArdle's disease with non-insulin-dependent diabetes mellitus: the beneficial effects of hyperglycemia and hyperinsulinemia for exercise intolerance.
Mcardle's disease. A case report.
MCARDLE'S DISEASE. HEREDITARY MYOPATHY DUE TO ABSENCE OF MUSCLE PHOSPHORYLASE.
McArdle's disease: a clinical review and case report.
McArdle's disease: a nonsense mutation in exon 1 of the muscle glycogen phosphorylase gene explains some but not all cases.
McArdle's disease: a rare frameshift mutation in exon 1 of the muscle glycogen phosphorylase gene.
McArdle's disease: a study on the molecular basis of two different etiologies of myophosphorylase deficiency.
McArdle's disease: case report and review of the literature.
MCARDLE'S DISEASE: HEREDITARY MYOPATHY DUE TO ABSENCE OF MUSCLE PHOSPHORYLASE.
McArdle's disease: lack of muscle phosphorylase.
McArdle's disease: molecular genetics and metabolic consequences of the phenotype.
Metabolic basis of improved exercise tolerance: muscle phosphorylase deficiency after glucagon administration.
Metabolic control of cardiac output response to exercise in McArdle's disease.
Minimally symptomatic mcardle disease, expanding the genotype-phenotype spectrum.
Missense mutations have unexpected consequences: The McArdle disease paradigm.
Molecular analysis of myophosphorylase deficiency in Dutch patients with McArdle's disease.
Molecular characterization of McArdle's disease in two large Finnish families.
Molecular characterization of myophosphorylase deficiency (McArdle disease) in 34 patients from Southern France: identification of 10 new mutations. Absence of genotype-phenotype correlation.
Molecular characterization of myophosphorylase deficiency in a group of patients from northern Italy.
Molecular diagnosis of McArdle disease: revised genomic structure of the myophosphorylase gene and identification of a novel mutation.
Molecular genetic heterogeneity of myophosphorylase deficiency (McArdle's disease).
Molecular genetic study of myophosphorylase deficiency (McArdle's disease) in two Yemenite-Jewish families.
Molecular heterogeneity in McArdle's disease.
Molecular heterogeneity of myophosphorylase deficiency (McArdle's disease): a genotype-phenotype correlation study.
Molecular mechanisms of McArdle's disease (muscle glycogen phosphorylase deficiency). RNA and DNA analysis.
Monocarboxylate transporters and mitochondrial creatine kinase protein content in McArdle disease.
MR imaging as a potential diagnostic test for metabolic myopathies: importance of variations in the T2 of muscle with exercise.
Muscle accumulation of Tc-99m diphosphonate in myophosphorylase deficiency and other disorders of muscle glycogenolysis/glycolysis.
Muscle fatigue in McArdle's disease studied by 31P-NMR: effect of glucose infusion.
Muscle fatigue in McArdle's disease. Muscle fibre conduction velocity and surface EMG frequency spectrum during ischaemic exercise.
Muscle fatigue in myophosphorylase deficiency: power spectral analysis of the electromyogram.
Muscle Glycogen Phosphorylase and Its Functional Partners in Health and Disease.
Muscle glycogen phosphorylase deficiency.
Muscle glycogenosis and mitochondrial hepatopathy in an infant with mutations in both the myophosphorylase and deoxyguanosine kinase genes.
Muscle molecular adaptations to endurance exercise training are conditioned by glycogen availability: a proteomics-based analysis in the McArdle mouse model.
Muscle pain in myophosphorylase deficiency (McArdle's disease): the role of gender, genotype, and pain-related coping.
Muscle phosphorylase deficiency in childhood.
MUSCLE PHOSPHORYLASE DEFICIENCY.
Muscle Signaling in Exercise Intolerance: Insights from the McArdle Mouse Model.
Muscle-type phosphorylase activity present in muscle cells cultured from three patients with myophosphorylase deficiency.
Mutation analysis in myophosphorylase deficiency (McArdle's disease).
Myofibrillar activation failure in McArdle's disease.
Myoglobinuria and skeletal muscle phosphorylase deficiency: report of a case of McArdle's disease.
Myopathies due to enzyme deficiencies.
Myophosphorylase (PYGM) mutations determined by next generation sequencing in a cohort from Turkey with McArdle disease.
Myophosphorylase deficiency (glycogen storage disease Type V) in a herd of Charolais cattle in New Zealand: confirmation by PCR-RFLP testing.
Myophosphorylase deficiency (glycogenosis type V; McArdle disease).
Myophosphorylase deficiency (McArdle disease) in a patient with normal pregnancy and normal pregnancy outcome.
Myophosphorylase deficiency (McArdle's disease) in two interrelated families.
Myophosphorylase deficiency (McArdle's disease): report of a family.
Myophosphorylase deficiency affects muscle mitochondrial respiration as shown by 31P-MR spectroscopy in a case with associated multifocal encephalopathy.
Myophosphorylase deficiency and limb-girdle muscular dystrophy in the same pedigree.
Myophosphorylase deficiency associated with a defect in complex I of the mitochondrial respiratory chain.
Myophosphorylase deficiency associated with rhabdomyolysis and exercise intolerance in 6 related Charolais cattle.
Myophosphorylase deficiency impairs muscle oxidative metabolism.
Myophosphorylase deficiency: an unusually severe form with myoglobinuria.
Myophosphorylase deficiency: the course of an unusual congenital myopathy.
Myophosphorylase deficiency: two different molecular etiologies.
Myophosphorylase gene transfer in McArdle's disease myoblasts in vitro.
No spontaneous second wind in muscle phosphofructokinase deficiency.
Normal pregnancy and successful delivery in myophosphorylase deficiency (McArdle's disease).
Novel variant in the PYGM gene causing late-onset limb-girdle myopathy, ptosis, and camptocormia.
Oxidative stress and Nrf2 signaling in McArdle disease.
Oxygen consumption is increased relative to work rate in patients with McArdle's disease.
Pathologic quiz case: a man with exertion-induced cramps and myoglobinuria. McArdle disease (glycogenosis type V or myophosphorylase deficiency).
Pathophysiology of exercise performance in muscle disease.
Peripheral nerve and vasculature involvement in myophosphorylase deficiency (McArdle's disease).
Pharmacological and nutritional treatment for McArdle disease (Glycogen Storage Disease type V).
Pharmacological and nutritional treatment for McArdle's disease (Glycogen Storage Disease type V).
Phenotype consequences of myophosphorylase dysfunction: insights from the McArdle mouse model.
Phenotype modulators in myophosphorylase deficiency.
Phosphoglycerate kinase deficiency in two brothers with McArdle-like clinical symptoms.
Phosphorus magnetic resonance spectroscopy (31P MRS) in neuromuscular disorders.
Phosphorylase isoenzymes in normal and myophosphorylase-deficient human heart.
Phosphorylase re-expression, increase in the force of contraction and decreased fatigue following notexin-induced muscle damage and regeneration in the ovine model of McArdle disease.
Phosphorylation of McArdle phosphorylase induces activity.
Physical training for McArdle disease.
Physiologic assessment of phosphoglycerate mutase deficiency: incremental exercise test.
PONM05 An unusual presentation of McArdle's disease.
PRES leading to the diagnosis of McArdle disease.
PYGM expression analysis in white blood cells: a complementary tool for diagnosing McArdle disease?
Recurrent Compartment Syndrome Leading to the Diagnosis of McArdle Disease: Case Report.
Recurrent myoglobinuria due to muscle carnitine palmityl transferase deficiency.
Recurrent rhabdomyolysis in a collegiate athlete: a case report.
Reflex sympathetic activation during static exercise is severely impaired in patients with myophosphorylase deficiency.
Research on molecular mechanisms of McArdle's disease (muscle glycogen phosphorylase deficiency). Use of new protein mapping and immunological techniques.
Results of an open label feasibility study of sodium valproate in people with McArdle disease.
Rhabdomyolysis in a patient with McArdle's disease.
Selective atrophy of type 1 muscle fibers in McArdle's disease.
Single-centre experience on genotypic and phenotypic features of southern Brazilian patients with McArdle disease.
Single-fiber electromyography in neuromuscular disorders: correlation of muscle histochemistry, single-fiber electromyography, and clinical findings.
Six novel mutations in the myophosphorylase gene in patients with McArdle disease and a family with pseudo-dominant inheritance pattern.
Skeletal muscle disorders of glycogenolysis and glycolysis.
Sodium valproate increases glycogen phosphorylase brain isoform: looking for a compensation mechanism in McArdle disease.
Splice mutations preserve myophosphorylase activity that ameliorates the phenotype in McArdle disease.
Splicing mosaic of the myophosphorylase gene due to a silent mutation in McArdle disease.
Spontaneous "second wind" and glucose-induced second "second wind" in McArdle disease: oxidative mechanisms.
Study of myopathy in chronic alcoholics with neurological complication.
Substrate kinetics in patients with disorders of skeletal muscle metabolism.
Sudden infant death syndrome (SIDS) in a family with myophosphorylase deficiency.
Systemic AAV8-mediated delivery of a functional copy of muscle glycogen phosphorylase (Pygm) ameliorates disease in a murine model of McArdle disease.
The clinical diagnosis of McArdle's disease. Identification of another family with deficiency of muscle phosphorylase.
The effect of three test meals on exercise tolerance of an individual with McArdle's disease.
The metabolic causes of slow relaxation in fatigued human skeletal muscle.
The molecular genetic basis of myophosphorylase deficiency (McArdle's disease).
The pathophysiology of McArdle's disease: clues to regulation in exercise and fatigue.
The production, buffering and efflux of protons in human skeletal muscle during exercise and recovery.
The role of lipid peroxidation in McArdle's disease: applications for treatment of other myopathies.
Therapeutic options in other metabolic myopathies.
Three new mutations in patients with myophosphorylase deficiency (McArdle disease).
Translational Medicine: Exercise Physiology Applied to Metabolic Myopathies.
Treatment of glycogenosys type V (McArdle disease) with creatine and ketogenic diet with clinical scores and with 31P-MRS on working leg muscle.
Tricarboxylic acid cycle intermediates during incremental exercise in healthy subjects and in patients with McArdle's disease.
Two homozygous mutations (R193W and 794/795 delAA) in the myophosphorylase gene in a patient with McArdle's disease.
Two new mutations in the myophosphorylase gene in Italian patients with McArdle's disease.
Two novel missense mutations (E654K, L396P) in Caucasian patients with myophosphorylase deficiency (McArdle's disease).
Two novel mutations in the muscle glycogen phosphorylase gene in McArdle's disease.
Two novel mutations in the myophosphorylase gene in a patient with McArdle disease.
Unforeseen Cardiac Involvement in McArdle's Disease.
Variable presentation of the clinical phenotype of McArdle's disease in a kindred harbouring a novel compound genotype in the muscle glycogen phosphorylase gene.
Various classes of mutations in patients with phosphofructokinase deficiency (Tarui's disease).
Wave of renal impairment.
Xanthine oxidase pathway and muscle damage. Insights from McArdle disease.
[Acute renal failure due to rhabdomyolysis in McArdle's disease following binge drinking with seizures]
[Anesthesia in a Patient with McArdle Disease].
[Glycogenosis type V of adults: muscle phosphorylase deficiency]
[Late diagnosis of a McArdle disease's case (type V glycogenosis).]
[Massive rhabdomyolysis revealing a McArdle disease.]
[McArdle disease revealed by exercise intolerance associated with severe rhabdomyolysis]
[McArdle disease: differential diagnosis of the increase in creatine kinase induced by the exercise test]
[McArdle disease: report of four brothers with myophosphorylase deficiency]
[MCARDLE'S DISEASE AND PHYSICAL ACTIVITY - A MIXED BLESSING].
[McArdle's disease in a 14-year-old girl with fatigability and raised muscle enzymes]
[McArdle's disease in adults: clinical and genetic study]
[McArdle's disease--description based on three own observations (author's transl)]
[McArdle's disease. Apropos of a case]
[Metabolic intolerance to exercise]
[Motor nerve conduction study in McArdle disease: case report]
[Muscle phosphorylase deficiency in childhood. A case report]
[Myalgia during warming-up in a 12-year-old boy].
[Myophosphorylase deficiency]
[On progressive myopathy with muscle phosphorylase deficiency and giant mitochondria]
[Private mutations in the myophosphorylase gene: the first case in a PATIENT of Latin American descent.]
[Rhabdomyolysis due to muscle enzyme deficiencies]
[Study of metabolic myopathies using 1H NMR spectroscopy--analysis of muscle metabolites and muscle autolytic change]
[Successful treatment with infliximab of a patient with refractory sarcoidosis]
Glycogen Storage Disease Type VI
Glycogen storage disease type VI: clinical course and molecular background.
Identification of a mutation in liver glycogen phosphorylase in glycogen storage disease type VI.
Liver Glycogen Phosphorylase Deficiency Leads to Profibrogenic Phenotype in a Murine Model of Glycogen Storage Disease Type VI.
Mutations in the liver glycogen phosphorylase gene (PYGL) underlying glycogenosis type VI.
Regional localization of loci on chromosome 14 using somatic cell hybrids.
Successful pregnancy in a woman with glycogen storage disease type 6.
The Phenotypic and Genetic Spectrum of Glycogen Storage Disease Type VI.
The polymorphic locus for glycogen storage disease VI (liver glycogen phosphorylase) maps to chromosome 14.
Glycogen Storage Disease Type VII
Free Mg2+ concentration in the calf muscle of glycogen phosphorylase and phosphofructokinase deficiency patients assessed in different metabolic conditions by 31P MRS.
Magnetic resonance imaging of muscle injury and atrophy in glycolytic myopathies.
Phosphoglycerate kinase deficiency in two brothers with McArdle-like clinical symptoms.
Sympathetic activation in exercise is not dependent on muscle acidosis. Direct evidence from studies in metabolic myopathies.
Glycosuria
Increase in liver protein phosphatase-1 in spontaneously diabetic Chinese hamsters.
Gout
Can hyperuricemia predict glycogen storage disease (McArdle's disease) in rheumatology practice? (Myogenic hyperuricemia).
Heart Diseases
Enzyme pattern in endomyocardial biopsies from patients with chronic heart diseases.
Phosphorylase isoenzymes in normal and myophosphorylase-deficient human heart.
[Biochemical markers in the diagnosis of acute coronary syndrome]
Hematologic Neoplasms
Glycogen phosphorylase BB could be a new biomarker for detection of cardiac toxicity during hematopoietic cell transplantation for hematological malignancies.
Hepatomegaly
Intermittent and recurrent hepatomegaly due to glycogen storage in a patient with type 1 diabetes: genetic analysis of the liver glycogen phosphorylase gene (PYGL).
The polymorphic locus for glycogen storage disease VI (liver glycogen phosphorylase) maps to chromosome 14.
Hydatidiform Mole
Glycogen metabolism in vesicles of hydatidiform mole in vitro.
Hyperandrogenism
A nontargeted study of muscle proteome in severely obese women with androgen excess compared with severely obese men and nonhyperandrogenic women.
Hyperglycemia
Advances in glycogen phosphorylase inhibitor design.
Alpha- and beta-cell responses to small changes in plasma glucose in the conscious dog.
Altered control of carbohydrate metabolism in endotoxemia.
Crystallographic studies on acyl ureas, a new class of glycogen phosphorylase inhibitors, as potential antidiabetic drugs.
Discovery of a Genetic Metabolic Cause for Mauriac Syndrome in Type 1 Diabetes.
Effects of acute variation of fetal glycemia on glycogen storage and on glycogen synthase and phosphorylase activities in the liver of the rat fetus.
Effects of hyperglycemia on hepatic gluconeogenic flux during glycogen phosphorylase inhibition in the conscious dog.
FR258900, a novel glycogen phosphorylase inhibitor isolated from Fungus No. 138354. I. Taxonomy, fermentation, isolation and biological activities.
Glycogen phosphorylase inhibition in type 2 diabetes therapy: a systematic evaluation of metabolic and functional effects in rat skeletal muscle.
Hyperglycemia associated with increased hepatic glycogen phosphorylase and phosphoenolpyruvate carboxykinase in rats following subchronic exposure to malathion.
Inability of hyperglycemia to counter the ability of glucagon to increase net glucose output and activate glycogen phosphorylase in the perfused rat liver.
Liver-specific iNOS expression is sufficient to cause hepatic insulin resistance and mild hyperglycemia in mice.
Mechanism by which glucose and insulin inhibit net hepatic glycogenolysis in humans.
Mode of action of dopamine in inducing hyperglycemia in the fresh water edible crab, Oziothelphusa senex senex.
Novel therapeutics based on inhibiting the interaction of glycogen phosphorylase and G(L)-subunit of glycogen-associated protein phosphatase 1: WO2009127723.
Prolonged inhibition of glycogen phosphorylase in livers of Zucker Diabetic Fatty rats models human glycogen storage diseases.
Sourcing the affinity of flavonoids for the glycogen phosphorylase inhibitor site via crystallography, kinetics and QM/MM-PBSA binding studies: Comparison of chrysin and flavopiridol.
Synthesis of 4-amidomethyl-1-glucosyl-1,2,3-triazoles and evaluation as glycogen phosphorylase inhibitors.
Synthesis of 5-halogenated 1,2,3-triazoles under stoichiometric Cu(I)-mediated azide-alkyne cycloaddition (CuAAC or 'Click Chemistry').
Hyperinsulinism
Mechanism by which glucose and insulin inhibit net hepatic glycogenolysis in humans.
Hyperlipidemias
Tests of potential adipokinetic hormone precursor related peptide (APRP) functions: lack of responses.
Hypersensitivity
A hypersensitivity of glycogen phosphorylase activation in hearts of diabetic rats.
Phosphorylase activation hypersensitivity in hearts of diabetic rats.
Hyperthyroidism
Effects of perhexiline on myocardial phosphorylase activity, myocardial catecholamine content and heart rate.
Glycogen and glycogen enzymes in the liver and striated muscle of rats under altered thyroid states.
Hyperthyroidism impairs the activation of glycogen phosphorylase by epinephrine in rat hepatocytes.
Mechanisms of enhanced phosphorylase activation in the hyperthyroid rat heart.
The effect of dibutyryl cyclic AMP on cardiac phosphorylase a activity in euthyroid and hyperthyroid hearts.
The effect of noradrenaline and tyramine on cardiac contractility, cyclic AMP, and phosphorylase a in normal and hyperthyroid rats.
Triiodo-L-thyronine stimulates glycogen synthesis in rat hepatocyte cultures.
Hypoglycemia
A fall in portal vein insulin does not cause the alpha-cell response to mild, non-insulin-induced hypoglycemia in conscious dogs.
Alpha- and beta-cell responses to small changes in plasma glucose in the conscious dog.
Altered Plasticity of Glycogen Phosphorylase in Forebrain Gliosomes Obtained from Insulinoma Patients.
Astrocyte glycogen sustains neuronal activity during hypoglycemia: studies with the glycogen phosphorylase inhibitor CP-316,819 ([R-R*,S*]-5-chloro-N-[2-hydroxy-3-(methoxymethylamino)-3-oxo-1-(phenylmethyl)propyl]-1H-indole-2-carboxamide).
Asymptomatic decreased activities of hepatic glucose-6-phosphatase and glycogen phosphorylase in a number of children with chronic liver disease.
Counterregulation of hypoglycemia. Skeletal muscle glycogen metabolism during three hours of physiological hyperinsulinemia in humans.
Glycogenic effect of an alkali soluble fraction from sepia shell.
Increased epinephrine and skeletal muscle responses to hypoglycemia in non-insulin-dependent diabetes mellitus.
Islet auto-transplantation into an omental or splenic site results in a normal beta cell but abnormal alpha cell response to mild non-insulin-induced hypoglycemia.
Liver glycogen metabolism during short-term insulin-induced hypoglycemia in fed rats.
Pancreatic response to mild non-insulin-induced hypoglycemia does not involve extrinsic neural input.
Postnatal profiles of glycogenolysis and gluconeogenesis are modified in rat pups by maternal dietary glucose restriction.
Hypokalemic Periodic Paralysis
Single-fiber electromyography in neuromuscular disorders: correlation of muscle histochemistry, single-fiber electromyography, and clinical findings.
Hypothyroidism
Coupled diminished energy turnover and phosphorylase a formation in contracting hypothyroid rat muscle.
Glycogen and glycogen enzymes in the liver and striated muscle of rats under altered thyroid states.
Phosphorylase a formation in protein-glycogen particles isolated from fast-twitch muscle of euthyroid and hypothyroid rats.
Infections
Adenovirus-mediated transfer of the muscle glycogen phosphorylase gene into hepatocytes confers altered regulation of glycogen metabolism.
Induction of protective immunity against Chlamydia muridarum intravaginal infection with a chlamydial glycogen phosphorylase.
Insulin Resistance
Chebulagic acid attenuates HFD/Streptozotocin induced impaired glucose metabolism and insulin resistance via up regulations of PPAR ? and GLUT 4 in type 2 diabetic rats.
Chiroinositol deficiency and insulin resistance. I. Urinary excretion rate of chiroinositol is directly associated with insulin resistance in spontaneously diabetic rhesus monkeys.
Glycogen phosphorylase inhibitor, 2,3-bis[(2E)-3-(4-hydroxyphenyl)prop-2-enamido] butanedioic acid (BF142), improves baseline insulin secretion of MIN6 insulinoma cells.
Inducible nitric oxide synthase plays a role in LPS-induced hyperglycemia and insulin resistance.
Insulin resistance limits glucose utilization and exercise tolerance in myophosphorylase deficiency and NIDDM.
Insulin sensitivity is modified by a glycogen phosphorylase inhibitor: glucopyranosylidene-spiro-thiohydantoin in streptozotocin-induced diabetic rats.
Intermittent fasting reduces body fat but exacerbates hepatic insulin resistance in young rats regardless of high protein and fat diets.
Mitigating Perspectives of Asiatic acid in the Renal derangements of Streptozotocin-Nicotinamide induced Diabetic Rats.
Pentacyclic triterpenoids from spikes of Prunella vulgaris L. inhibit glycogen phosphorylase and improve insulin sensitivity in 3T3-L1 adipocytes.
The effect of alcohol on blood glucose in Type 1 diabetes--metabolic modelling and integration in a decision support system.
Insulinoma
Altered Plasticity of Glycogen Phosphorylase in Forebrain Gliosomes Obtained from Insulinoma Patients.
Glycogen phosphorylase inhibitor, 2,3-bis[(2E)-3-(4-hydroxyphenyl)prop-2-enamido] butanedioic acid (BF142), improves baseline insulin secretion of MIN6 insulinoma cells.
Ischemic Stroke
New biomarker for acute ischaemic stroke: plasma glycogen phosphorylase isoenzyme BB.
Lacrimal Apparatus Diseases
Ectropion and epiphora in McArdle's syndrome.
Leukemia
Glycogen phosphorylase BB as a potential marker of cardiac toxicity in patients treated with anthracyclines for acute leukemia.
Renal carcinogenesis in models of diabetes in rats: metabolic changes are closely related to neoplastic development.
Response variability in Attention-Deficit Hyperactivity Disorder: A neuronal and glial energetics hypothesis.
[Enzyme histochemical studies of malignant tumors in childhood. 2. Enzyme histochemical study on beta-glucuronidase and amylophosphorylase in acute leukemia]
Liver Cirrhosis
Restoration of the glycogen-forming function of hepatocytes in rats with liver cirrhosis is facilitated by a high-carbohydrate diet.
Liver Cirrhosis, Biliary
Anti-M9 antibodies in sera from patients with primary biliary cirrhosis recognize an epitope of glycogen phosphorylase.
M4 and M9 autoantigens in primary biliary cirrhosis--a negative study.
Liver Diseases
Asymptomatic decreased activities of hepatic glucose-6-phosphatase and glycogen phosphorylase in a number of children with chronic liver disease.
Chronic liver disease and impaired hepatic glycogen metabolism in argininosuccinate lyase deficiency.
Liver Failure
Muscle glycogenosis and mitochondrial hepatopathy in an infant with mutations in both the myophosphorylase and deoxyguanosine kinase genes.
Liver Neoplasms
Carcinofetal alterations in glycogen phosphorylase isozymes in rat hepatomas.
Liver Neoplasms, Experimental
Glycogen phosphorylase isoenzymes from hepatoma 3924A and from a non-tumorigenic liver cell line. Comparison with the liver and brain enzymes.
Purification and characterization of the Novikoff hepatoma glycogen phosphorylase and its relations to a fetal form.
Lung Neoplasms
Glycogen phosphorylase B promotes cell proliferation and migration through PI3K/AKT pathway in non-small cell lung cancer.
PYGB Promoted Tumor Progression by Regulating Wnt/?-Catenin Pathway in Gastric Cancer.
Metabolism, Inborn Errors
Substrate kinetics in patients with disorders of skeletal muscle metabolism.
Mitochondrial Myopathies
Impaired oxygen extraction in metabolic myopathies: detection and quantification by near-infrared spectroscopy.
Pathophysiology of exercise performance in muscle disease.
Sympathetic activation in exercise is not dependent on muscle acidosis. Direct evidence from studies in metabolic myopathies.
Translational Medicine: Exercise Physiology Applied to Metabolic Myopathies.
Multiple Endocrine Neoplasia
The germinal center kinase gene and a novel CDC25-like gene are located in the vicinity of the PYGM gene on 11q13.
Multiple Endocrine Neoplasia Type 1
The germinal center kinase gene and a novel CDC25-like gene are located in the vicinity of the PYGM gene on 11q13.
Multiple Myeloma
Abnormal platelet glycogen metabolism in multiple myeloma patients.
Muscle Cramp
A novel PHKA1 mutation associating myopathy and cognitive impairment: Expanding the spectrum of phosphorylase kinase b (PhK) deficiency.
Acid maltase deficiency and related myopathies.
Aerobic conditioning: an effective therapy in McArdle's disease.
Cloning of bovine muscle glycogen phosphorylase cDNA and identification of a mutation in cattle with myophosphorylase deficiency, an animal model for McArdle's disease.
Laboratory diagnosis of the neuromuscular glycogen storage diseases.
McArdle's disease in childhood: report of a new case.
McArdle's disease presenting with asymmetric, late-onset arm weakness.
McArdle's disease: case report and review of the literature.
Molecular genetic heterogeneity of myophosphorylase deficiency (McArdle's disease).
Muscle phosphorylase deficiency in childhood.
Pathologic quiz case: a man with exertion-induced cramps and myoglobinuria. McArdle disease (glycogenosis type V or myophosphorylase deficiency).
Phenotype modulators in myophosphorylase deficiency.
The molecular genetic basis of myophosphorylase deficiency (McArdle's disease).
Muscle Weakness
A novel PHKA1 mutation associating myopathy and cognitive impairment: Expanding the spectrum of phosphorylase kinase b (PhK) deficiency.
Myopathies due to enzyme deficiencies.
Muscular Atrophy
Effect of denervation on the expression of glycogen phosphorylase in mouse skeletal muscle.
Reduced glycogen phosphorylase activity in denervated hindlimb muscles of rat is related to muscle atrophy and fibre type.
Muscular Diseases
A case of McArdle disease: efficacy of vitamin B6 on fatigability and impaired glycogenolysis.
A metabolic myopathy due to absence of muscle phosphorylase.
A multi-parametric protocol to study exercise intolerance in McArdle's disease.
A proposed molecular diagnostic flowchart for myophosphorylase deficiency (McArdle disease) in blood samples from Spanish patients.
A splice-site mutation causing ovine McArdle's disease.
Acid maltase deficiency and related myopathies.
Acute renal failure in McArdle's disease.
An elderly diabetic patient with McArdle disease and recurrent rhabdomyolysis: a potential association with late hypoinsulinemia?
Analysis of spectrum and frequencies of mutations in McArdle disease. Identification of 13 novel mutations.
Clinical and laboratory features of patients with myophosphorylase deficiency (McArdle disease).
Clinical spectrum of McArdle disease: three cases with unusual expression.
Cloning of bovine muscle glycogen phosphorylase cDNA and identification of a mutation in cattle with myophosphorylase deficiency, an animal model for McArdle's disease.
Congenital and metabolic myopathies of childhood or adult onset.
Congenital myopathy due to phosphorylase deficiency.
Expression of muscle-type phosphorylase in innervated and aneural cultured muscle of patients with myophosphorylase deficiency.
McArdle Disease and Exercise Physiology.
McArdle disease: a case report and review.
McArdle Disease: New Insights into Its Underlying Molecular Mechanisms.
McArdle disease: what do neurologists need to know?
McArdle's disease presenting with asymmetric, late-onset arm weakness.
MCARDLE'S DISEASE. HEREDITARY MYOPATHY DUE TO ABSENCE OF MUSCLE PHOSPHORYLASE.
MCARDLE'S DISEASE: HEREDITARY MYOPATHY DUE TO ABSENCE OF MUSCLE PHOSPHORYLASE.
Molecular mechanisms of McArdle's disease (muscle glycogen phosphorylase deficiency). RNA and DNA analysis.
Monocarboxylate transporters and mitochondrial creatine kinase protein content in McArdle disease.
MR imaging as a potential diagnostic test for metabolic myopathies: importance of variations in the T2 of muscle with exercise.
Muscle glycogenosis and mitochondrial hepatopathy in an infant with mutations in both the myophosphorylase and deoxyguanosine kinase genes.
Myopathies due to enzyme deficiencies.
Myophosphorylase deficiency affects muscle mitochondrial respiration as shown by 31P-MR spectroscopy in a case with associated multifocal encephalopathy.
Myophosphorylase deficiency: the course of an unusual congenital myopathy.
Oxidative stress and Nrf2 signaling in McArdle disease.
Physical training for McArdle disease.
Selective atrophy of type 1 muscle fibers in McArdle's disease.
Single-centre experience on genotypic and phenotypic features of southern Brazilian patients with McArdle disease.
The effect of three test meals on exercise tolerance of an individual with McArdle's disease.
The molecular genetic basis of myophosphorylase deficiency (McArdle's disease).
Translational Medicine: Exercise Physiology Applied to Metabolic Myopathies.
Unforeseen Cardiac Involvement in McArdle's Disease.
[Late diagnosis of a McArdle disease's case (type V glycogenosis).]
[McArdle disease revealed by exercise intolerance associated with severe rhabdomyolysis]
[MCARDLE'S DISEASE AND PHYSICAL ACTIVITY - A MIXED BLESSING].
[McArdle's disease in adults: clinical and genetic study]
[Motor nerve conduction study in McArdle disease: case report]
[Myalgia during warming-up in a 12-year-old boy].
[On progressive myopathy with muscle phosphorylase deficiency and giant mitochondria]
[Private mutations in the myophosphorylase gene: the first case in a PATIENT of Latin American descent.]
[Rhabdomyolysis due to muscle enzyme deficiencies]
[Successful treatment with infliximab of a patient with refractory sarcoidosis]
Muscular Dystrophies
[STUDIES ON MUSCLE PHOSPHORYLASE ACTIVITY IN PROGRESSIVE MUSCULAR DYSTROPHY.]
Muscular Dystrophies, Limb-Girdle
Myophosphorylase deficiency and limb-girdle muscular dystrophy in the same pedigree.
Myalgia
A novel PHKA1 mutation associating myopathy and cognitive impairment: Expanding the spectrum of phosphorylase kinase b (PhK) deficiency.
Acid maltase deficiency and related myopathies.
McArdle's disease presenting with asymmetric, late-onset arm weakness.
McArdle's disease: case report and review of the literature.
Muscle pain in myophosphorylase deficiency (McArdle's disease): the role of gender, genotype, and pain-related coping.
[McArdle disease: differential diagnosis of the increase in creatine kinase induced by the exercise test]
Myocardial Infarction
Design, Synthesis, and Use of Novel Photoaffinity Probes in Measuring the Serum Concentration of Glycogen Phosphorylase.
Diagnostic accuracy of heart fatty acid binding protein (H-FABP) and glycogen phosphorylase isoenzyme BB (GPBB) in diagnosis of acute myocardial infarction in patients with acute coronary syndrome.
Glycogen phosphorylase BB in myocardial infarction.
Glycogen Phosphorylase BB: A more Sensitive and Specific Marker than Other Cardiac Markers for Early Diagnosis of Acute Myocardial Infarction.
Glycogen phosphorylase isoenzyme BB in the diagnosis of acute myocardial infarction: a meta-analysis.
Glycogen phosphorylase isoenzyme BB mass release after coronary artery bypass grafting.
Immunoenzymometric assay of human glycogen phosphorylase isoenzyme BB in diagnosis of ischemic myocardial injury.
Isoenzyme BB of glycogen phosphorylase b and myocardial infarction.
Serum glycogen phosphorylase b: a new enzyme test for myocardial infarction.
The assay of glycogen phosphorylase in human blood serum and its application to the diagnosis of myocardial infarction.
[Base activity of glycogen phosphorylase b in human serum. Study of reference and discrimination values]
[Determination of glycogen phosphorylase B--a contribution to the enzymatic diagnosis of acute myocardial infarct]
[Dynamics of blood glycogen phosphorylase during acute myocardial infarct]
[Effect of physical loading on serum enzyme activity in post-myocardial infarct patients]
[Glycogen phosphorylase activity in acute myocardial infarction]
[Glycogen phosphorylase activity in infarct-affected and nonaffected parts of the human myocardium after death]
[Glycogen phosphorylase b: a new serum enzyme test for myocardial infarct]
[Immunoinhibition test for human glycogen phosphorylase BB in the diagnosis of acute myocardial infarct]
[Relationship between glycogen phosphorylase BB and cardiac ischemic area or infarction area in experimental acute myocardial infarction.]
[Separation of glycogen phosphorylase isoenzymes using electrophoresis in acetate cellulose]
[The determination of the glycogen phosphorylase activity in blood serum]
Myocardial Ischemia
Glycogen phosphorylase isoenzyme BB plasma concentration is elevated in pregnancy and preterm preeclampsia.
Glycogen phosphorylase isoenzyme BB plasma kinetics is not related to myocardial ischemia induced by exercise stress echo test.
On the mechanism of action of the antianginal drug nonachlazine on ischemic myocardium.
[Base activity of glycogen phosphorylase b in human serum. Study of reference and discrimination values]
Myocarditis
Enzyme pattern and lipid peroxides in endomyocardial biopsies from patients with cardiomyopathy and myocarditis.
Myoglobinuria
A novel PHKA1 mutation associating myopathy and cognitive impairment: Expanding the spectrum of phosphorylase kinase b (PhK) deficiency.
Clinical and laboratory features of patients with myophosphorylase deficiency (McArdle disease).
Cloning of bovine muscle glycogen phosphorylase cDNA and identification of a mutation in cattle with myophosphorylase deficiency, an animal model for McArdle's disease.
Dominant inheritance of McArdle syndrome.
Glycogen storage diseases of muscle.
Laboratory diagnosis of the neuromuscular glycogen storage diseases.
McArdle's disease presenting with asymmetric, late-onset arm weakness.
McArdle's disease: case report and review of the literature.
Molecular genetic heterogeneity of myophosphorylase deficiency (McArdle's disease).
Muscle phosphorylase deficiency in childhood.
Myoglobinuria and skeletal muscle phosphorylase deficiency: report of a case of McArdle's disease.
Myophosphorylase deficiency (glycogenosis type V; McArdle disease).
Myophosphorylase deficiency associated with a defect in complex I of the mitochondrial respiratory chain.
Myophosphorylase deficiency: an unusually severe form with myoglobinuria.
Pathologic quiz case: a man with exertion-induced cramps and myoglobinuria. McArdle disease (glycogenosis type V or myophosphorylase deficiency).
Pharmacological and nutritional treatment for McArdle disease (Glycogen Storage Disease type V).
Phenotype modulators in myophosphorylase deficiency.
Recurrent myoglobinuria due to muscle carnitine palmityl transferase deficiency.
The molecular genetic basis of myophosphorylase deficiency (McArdle's disease).
[Clinical demonstrations of hereditary disorders of metabolism]
Myoma
[Properties of glycogen phosphorylase B from human uterine myoma]
Myopathies, Nemaline
Congenital and metabolic myopathies of childhood or adult onset.
Myositis
Muscle biopsy features in critical ill patients with 2009 influenza A (H1N1) virus infection.
Myotonia Congenita
Single-fiber electromyography in neuromuscular disorders: correlation of muscle histochemistry, single-fiber electromyography, and clinical findings.
Neoplasm Metastasis
Fibroblasts Mobilize Tumor Cell Glycogen to Promote Proliferation and Metastasis.
PYGB Promoted Tumor Progression by Regulating Wnt/?-Catenin Pathway in Gastric Cancer.
Neoplasms
Activity of enzymes related to carbohydrate metabolism in the HT 29 colon adenocarcinoma cell line and tumor.
Assignment of the human FAU gene to a subregion of chromosome 11q13.
Breast cancers utilize hypoxic glycogen stores via PYGB, the brain isoform of glycogen phosphorylase, to promote metastatic phenotypes.
Comprehensive analysis of multi Ewing sarcoma microarray datasets identifies several prognosis biomarkers.
Does dexmedetomidine have a cardiac protective effect during non-cardiac surgery? A randomised controlled trial.
Effect of alkylating agents on glycogen phosphorylase activity of ascites tumor cells.
Fibroblasts Mobilize Tumor Cell Glycogen to Promote Proliferation and Metastasis.
Genomic cloning of methylthioadenosine phosphorylase: a purine metabolic enzyme deficient in multiple different cancers.
Glucose utilization via glycogen phosphorylase sustains proliferation and prevents premature senescence in cancer cells.
Glycogen phosphorylase activities of tumors, regenerating rat liver and suckling rat liver.
Glycogen Phosphorylase B Is Regulated by miR101-3p and Promotes Hepatocellular Carcinoma Tumorigenesis.
Glycogen phosphorylase B promotes cell proliferation and migration through PI3K/AKT pathway in non-small cell lung cancer.
Glycogen phosphorylase B promotes ovarian cancer progression via Wnt/?-catenin signaling and is regulated by miR-133a-3p.
Glycogen phosphorylase hyperactive foci of altered hepatocytes in aged rats.
Growth-related enzymatic control of glycogen metabolism in cultured human tumor cells.
Increased sensitivity to glucose starvation correlates with downregulation of glycogen phosphorylase isoform PYGB in tumor cell lines resistant to 2-deoxy-D-glucose.
Inhibition of glycogen phosphorylase (GP) by CP-91,149 induces growth inhibition correlating with brain GP expression.
Isozymes of glycogen phosphorylase in human cartilage and cartilage tumors.
Linking glycogen and senescence in cancer cells.
Metabolic phenotype of bladder cancer.
Metabolic sensitivity of pancreatic tumour cell apoptosis to glycogen phosphorylase inhibitor treatment.
Methylthioadenosine phosphorylase, a gene frequently codeleted with p16(cdkN2a/ARF), acts as a tumor suppressor in a breast cancer cell line.
Muscle Glycogen Phosphorylase and Its Functional Partners in Health and Disease.
Novel subtyping of intestinal metaplasia in the human stomach: brain-type glycogen phosphorylase expression in the proliferative zone and its relationship with carcinogenesis.
Papillary eccrine adenoma. A tubulopapillary hidradenoma with eccrine differentiation.
Pharmacology and clinical status of capecitabine.
Phosphorylase: a new isozyme in rat hepatic tumors and fetal liver.
PYGB facilitates cell proliferation and invasion in non-small cell lung cancer through activating Wnt/?-catenin signaling.
PYGB Promoted Tumor Progression by Regulating Wnt/?-Catenin Pathway in Gastric Cancer.
PYGB siRNA inhibits the cell proliferation of human osteosarcoma cell lines.
Selective killing of tumors deficient in methylthioadenosine phosphorylase: a novel strategy.
Synthesis, Kinetic and Conformational Studies of 2-Substituted-5-(?-d-glucopyranosyl)-pyrimidin-4-ones as Potential Inhibitors of Glycogen Phosphorylase.
Targeting glycogen metabolism in bladder cancer.
The different expression of glycogen phosphorylases in renal clear cell renal carcinoma and chromophobe renal carcinoma.
The germinal center kinase gene and a novel CDC25-like gene are located in the vicinity of the PYGM gene on 11q13.
Tumor hypoglycemia induced in nude mice by a heterotransplantable human ovarian carcinoma line (OCL-1).
[A histochemical study of the effect of progesterone on the carbohydrate metabolism enzymes of different morphologic forms of endometrial cancer]
[Biochemical investigations of cancer cachexia. II. Depletion of glycogenolysis and stimulation of gluconeogenesis in Walker carcinoma 256 bearing rats (author's transl)]
[Enzyme histochemical studies of malignant tumors in childhood. 2. Enzyme histochemical study on beta-glucuronidase and amylophosphorylase in acute leukemia]
[Histochemical studies on intracellular glycogen metabolism in AH 13 ascites tumor cells. 2. AH 13 cell cycle and intracellular reaction of glycogen, phosphorylase and UDPG-glycogen glucosyltransferase]
Non-alcoholic Fatty Liver Disease
The traditional Chinese formulae Ling-gui-zhu-gan decoction alleviated non-alcoholic fatty liver disease via inhibiting PPP1R3C mediated molecules.
Obesity
Obesity and the regulation of phosphofructokinase in heart: an apparent insensitivity to adrenergic activation in mature-age genetically obese rats.
Osteoarthritis
Carnosine, taurine and enzyme activities of human skeletal muscle fibres from elderly subjects with osteoarthritis and young moderately active subjects.
Osteoarthritis, Knee
Carnosine, taurine and enzyme activities of human skeletal muscle fibres from elderly subjects with osteoarthritis and young moderately active subjects.
Ovarian Neoplasms
Glycogen phosphorylase B promotes ovarian cancer progression via Wnt/?-catenin signaling and is regulated by miR-133a-3p.
Pancreatic Neoplasms
Inhibition of Glycogen Phosphorylation Induces Changes in Cellular Proteome and Signaling Pathways in MIA Pancreatic Cancer Cells.
The intracellular mechanism of insulin resistance in pancreatic cancer patients.
Paralysis
Internal restriction sites: quality assurance aids in genotyping.
Single-fiber electromyography in neuromuscular disorders: correlation of muscle histochemistry, single-fiber electromyography, and clinical findings.
Paralysis, Hyperkalemic Periodic
Internal restriction sites: quality assurance aids in genotyping.
Pheochromocytoma
Activation of glycogen phosphorylase in rat pheochromocytoma PC12 cells and isolated hepatocytes by organophosphates.
Calcium-dependent activation of glycogen phosphorylase in rat pheochromocytoma PC12 cells by nerve growth factor.
phosphorylase kinase deficiency
Adult-onset exercise intolerance due to phosphorylase b kinase deficiency.
Characterization of the phosphorylase b to a converting activity in skeletal muscle extracts of mice with the phosphorylase b kinase deficiency mutation.
Clinical and biochemical features of 10 adult patients with muscle phosphorylase kinase deficiency.
Fueling around with glycogen: the implications of muscle phosphorylase b kinase deficiency.
Genetic deficiencies of the glycogen phosphorylase system.
Glycogen phosphorylase and its converter enzymes in haemolysates of normal human subjects and of patients with type VI glycogen-storage disease. A study of phosphorylase kinase deficiency.
Glycogenosis due to liver and muscle phosphorylase kinase deficiency.
Muscle phosphorylase b kinase deficiency revisited.
Muscle phosphorylase kinase deficiency: a neutral metabolic variant or a disease?
Skeletal muscle phosphorylase kinase deficiency: detection of a protein lacking any activity in ICR-IAn mice.
The molecular basis of skeletal muscle phosphorylase kinase deficiency.
The phosphorylase kinase activity of hearts from phosphorylase kinase-deficient mice.
Use of platelets, mononuclear and polymorphonuclear cells in the diagnosis of glycogen storage disease type VI.
X-linked dominant inheritance of partial phosphorylase kinase deficiency in mice.
Porphyrias, Hepatic
Response of glucose metabolism enzymes in an acute porphyria model. Role of reactive oxygen species.
Pre-Eclampsia
Altered Maternal Plasma Glycogen Phosphorylase Isoenzyme BB as a Biomarker for Preeclampsia and Small for Gestational Age.
Assessment of glycogen phosphorylase isoenzyme BB as a biomarker for pre-eclampsia and small for gestational age.
cDNA microarray analysis of gene expression profiles in human placenta: up-regulation of the transcript encoding muscle subunit of glycogen phosphorylase in preeclampsia.
Glycogen phosphorylase isoenzyme BB plasma concentration is elevated in pregnancy and preterm preeclampsia.
Markers of maternal cardiac dysfunction in pre-eclampsia and superimposed pre-eclampsia.
PP054. Elevated maternal plasma glycogen phosphorylase isoenzyme BB as time of disease biomarker of pre-eclampsia and small-for-gestational-age.
Prostatic Neoplasms
Targeting glycogen metabolism in bladder cancer.
Pseudohypoparathyroidism
Phosphorylase a deficiency in pseudohypoparathyroidism.
Pulmonary Disease, Chronic Obstructive
Muscle fiber type IIX atrophy is involved in the loss of fat-free mass in chronic obstructive pulmonary disease.
Renal Insufficiency
McArdle's disease presenting as recurrent cryptogenic renal failure due to occult seizures.
Reperfusion Injury
Cardioprotective effects of ingliforib, a novel glycogen phosphorylase inhibitor.
Respiratory Insufficiency
Fatal arthrogryposis with respiratory insufficiency: a possible case of muscle phosphorylase b-kinase deficiency.
Retinoblastoma
Inducible expression of catalytically active type 1 serine/threonine protein phosphatase in a human carcinoma cell line.
Separation of PP2A core enzyme and holoenzyme with monoclonal antibodies against the regulatory A subunit: abundant expression of both forms in cells.
Rhabdomyolysis
Acute renal failure in McArdle's disease.
Aerobic conditioning: an effective therapy in McArdle's disease.
False negative histochemical reaction for myophosphorylase activity in fulminant sepsis due to methicillin resistant Staphylococcus aureus.
Myophosphorylase deficiency associated with rhabdomyolysis and exercise intolerance in 6 related Charolais cattle.
Natural history of potassium-deficiency myopathy in the dog: role of adrenocorticosteroid in rhabdomyolysis.
Pharmacological and nutritional treatment for McArdle disease (Glycogen Storage Disease type V).
Substrate kinetics in patients with disorders of skeletal muscle metabolism.
[Rhabdomyolysis due to muscle enzyme deficiencies]
Rhabdomyosarcoma
An evaluation of enzyme histochemistry in the diagnosis of childhood rhabdomyosarcoma.
Sarcoidosis, Pulmonary
[Successful treatment with infliximab of a patient with refractory sarcoidosis]
Sarcoma, Myeloid
Enzymes of glycogen metabolism in white blood cells. 3. Heterogeneity of glycogen phosphorylase from rat chloroma.
Enzymes of glycogen metabolism in white blood cells. II. Activation and inactivation of glycogen phosphorylase of rat chloroma.
Seizures
Changes in glycogen phosphorylase activity and glycogen levels of mouse cerebral cortex during convulsions induced by homocysteine.
Changes of cyclic AMP and phosphorylase a in mouse cerebral cortex during seizures induced by 3-mercaptopropionic acid.
Convulsions as the etiology of lactic acidosis in acute diazinon toxicity in rats.
Glycogen phosphorylase activity in the cerebral cortex of rats during development: effect of homocysteine-induced seizures.
McArdle's disease presenting as recurrent cryptogenic renal failure due to occult seizures.
Sepsis
False negative histochemical reaction for myophosphorylase activity in fulminant sepsis due to methicillin resistant Staphylococcus aureus.
Perturbation of transmembrane signaling mechanisms in acute and chronic endotoxemia.
Protein phosphorylation in isolated hepatocytes of septic and endotoxemic rats.
Rat liver free cytosolic Ca2+ and glycogen phosphorylase in endotoxicosis and sepsis.
The Diagnostic Value of Plasma miRNA-497, cTnI, FABP3 and GPBB in Pediatric Sepsis Complicated with Myocardial Injury.
Shock, Septic
Liver glycogen metabolism in endotoxin shock. II. Endotoxin administration increases glycogen phosphorylase activities in dog livers.
Skin Abnormalities
[Clinical and biochemical alterations in rats treated with high doses of vitamin A]
Sleep Deprivation
Sleep deprivation modulates brain mRNAs encoding genes of glycogen metabolism.
Starvation
Activity of enzymes regulating glycogen metabolism in perfused muscle-cuticle sections of Ascaris suum (Nematoda).
Activity of glycogen metabolizing enzymes in glucose deprived HT 29 adenocarcinoma cell-line.
Carbohydrate metabolism during starvation in the silkworm Bombyx mori.
Developmental changes in the response of larval Manduca sexta fat body glycogen phosphorylase to starvation, stress and octopamine.
Effect of starvation on glycogen and glucose metabolism in different areas of the rat brain.
Effects of starvation on the carbohydrate metabolism in Harmonia axyridis (Pallas).
Enzyme Sets of Glycolysis, Gluconeogenesis, and Oxidative Pentose Phosphate Pathway Are Not Complete in Nongreen Highly Purified Amyloplasts of Sycamore (Acer pseudoplatanus L.) Cell Suspension Cultures.
Hormonal regulation of fat body glycogen phosphorylase activity in larval Manduca sexta during starvation.
Increased sensitivity to glucose starvation correlates with downregulation of glycogen phosphorylase isoform PYGB in tumor cell lines resistant to 2-deoxy-D-glucose.
Physiological role of skeletal muscle glycogen in starved mice.
Sequencing and characterization of glycogen synthase and glycogen phosphorylase genes from Spodoptera exigua and analysis of their function in starvation and excessive sugar intake.
Significance of the increase in glucose 6-phosphatase activity in skeletal muscle cells of the mouse by starvation.
The behavior of muscle phosphorylase as a reservoir for vitamin B6 in the rat.
The effects of fasting and refeeding on liver glycogen synthase and phosphorylase in obese and lean mice.
The putative AKH receptor of the tobacco hornworm, Manduca sexta, and its expression.
Status Epilepticus
Acute and chronic changes in glycogen phosphorylase in hippocampus and entorhinal cortex after status epilepticus in the adult male rat.
Stomach Neoplasms
Carcinogenesis of intestinal-type gastric cancer and colorectal cancer is commonly accompanied by expression of brain (fetal)-type glycogen phosphorylase.
Gastric and intestinal phenotypes of gastric carcinoma with reference to expression of brain (fetal)-type glycogen phosphorylase.
PYGB Promoted Tumor Progression by Regulating Wnt/?-Catenin Pathway in Gastric Cancer.
Tetanus
Metabolic adaptation in phosphorylase kinase deficiency. Changes in metabolite concentrations during tetanic stimulation of mouse leg muscles.
Tremor
Convulsions as the etiology of lactic acidosis in acute diazinon toxicity in rats.
Tuberculosis
Duplicated gene clusters suggest an interplay of glycogen and trehalose metabolism during sequential stages of aerial mycelium development in Streptomyces coelicolor A3(2).
Synthesis, molecular modeling and bio-evaluation of cycloalkyl fused 2-aminopyrimidines as antitubercular and antidiabetic agents.
Urethritis
Identification and characterization of immunogenic proteins of mycoplasma genitalium.
Urinary Incontinence
Stress urinary incontinence in women. III. Different tissue biochemistry in patients with concomitant detrusor instability. Preliminary report.
Vitamin B 12 Deficiency
Periodic acid-schiff-positive megaloblasts in pernicious anemia.
Vitamin B 6 Deficiency
Effect of vitamin B6 deficiency on the expression of glycogen phosphorylase mRNA in rat liver and skeletal muscle.
The behavior of muscle phosphorylase as a reservoir for vitamin B6 in the rat.
The effect of pyridoxine deficiency on liver and muscle phosphorylase.
Vitamin K Deficiency
[Skeletal muscle phosphorylase and hexokinase activity in vitamin K deficiency and the effect of several 6-hydroxychromane derivatives on changes in hexokinase activity]
Whooping Cough
Inhibition of epinephrine-induced glycogen phosphorylase activation by Bordetella pertussis vaccine in rats.
Synthetic peptides based on the calmodulin-binding domain of myosin light chain kinase inhibit activation of other calmodulin-dependent enzymes.